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During development oligodendrocytes in the central nervous system (CNS) produce large amount of 
membrane to generate myelin which wraps around the axons. The synthesis, maintenance and 
turnover of such enormous amounts of myelin membranes are crucial for the maintenance of 
functional nerves. How molecules within the numerous layers of tightly compacted membrane get 
access to the degradation system for myelin turnover is not well known. In this work, we observed 
that microglia are in contact with myelin via their processes, and myelin fragments, generated due to 
myelin breakdown, are engulfed by these cells at 18 and 24 months of age. We could show that 
microglia are actively engaged in clearing away degenerated myelin in normal aging.  
 
To investigate the connection between myelin breakdown and phenotypic changes in microglia, 
demyelinating mouse models were analysed. The results showed that microglia in these mice 
specifically develop large amount of lysosomal inclusions that include internalized myelin 
components.   
 In general, such inclusions are typically observed in aged post-mitotic cells and are called aging 
pigment or lipofuscin.  
 
To test whether impairing the lysosomal system is sufficient to induce an aging phenotype, 
we generated mice in which the lysosomal degradation pathway was specifically blocked in microglia. 
This was achieved by deleting the gene encoding Rab7 which is essential for maturation of 
lysosomes. In these mice, aged microglia with large inclusions was induced already when the mice 
were 10 weeks old. Already at 5 months of age the clearance function impaired and the number of 
extracellular myelin fragments increased. Using Rab7 KO mice we confirmed the role of microglia 
cells in clearing myelin in normal aging, and also induced a phenotype related to aging. 
These findings indicate that myelin breakdown can lead to lysosomal inclusion and impairs the 
clearance function of microglia.  
Since the clearance function is important for the cell function to fight against aging, our results may 
have important implication for multiple sclerosis and neurodegenerative disease associated with 










1.1.1 Microglia origin and development 
Microglia are resident phagocytic cells in the central nervous system (CNS) which form 5-20% of the 
total glial cell population (non-neuronal cells) (Lawson, Perry et al. 1990; Perry 1998). Microglia 
originate from myeloid progenitors in the yolk sac before embryonic day 8; they migrate and 
proliferate in the parenchyma during development. (Alliot, Godin et al. 1999; Ginhoux, Greter et al. 
2010; Ginhoux, Lim et al. 2013; Prinz and Priller 2014). Microglia are long-lived cells and their 
population is maintained in the CNS by self-renewing in physiological condition during adulthood 
(Lawson, Perry et al. 1992; Ajami, Bennett et al. 2007). 
 
1.1.2 Microglia phenotype in central nervous system 
In normal conditions, microglia are in their ramified shape with long and highly branched processes. 
In this stage, the cells are considered to be in the “resting” state when they express macrophage-
specific molecules like Iba1 (ionized calcium-binding adapter molecule 1), F4/80 and CX3CR1 (CX3C 
chemokine receptor 1 or Fractalkine receptor) (Kettenmann, Hanisch et al. 2011; Prinz, Priller et al. 
2011). During injury due to the loss of brain homeostasis, microglia become activated and change 
their morphology to an amoeboid form with retracted and less complex processes. In addition, their 
gene expression profile changes and  pro-inflammatory cytokines like TNF-α (Tumor necrosis factor 
alpha), IL-1β (Interleukin 1 beta), and IL-6 (Interleukin 6) as well as activation markers such as MHCII 
(major histocompatibility complex II), FcγRII (Fc gamma receptor II), and iNOS (inducible Nitric Oxide 
Synthase) are expressed (Kettenmann, Hanisch et al. 2011). 
 
1.1.3 Microglia function in central nervous system 
Microglia cells have a variety of functions including surveillance, pruning, phagocytic and 




development, adulthood, and aging in healthy and injured brain (Perry, Nicoll et al. 2010; Ginhoux, 
Lim et al. 2013; Perry and Teeling 2013; Gomez-Nicola and Perry 2015).  
1.1.3.1 Microglia in normal brain 
The classical view about microglia was that when they are in their resting state with the ramified 
morphology, they shut down most of their functions. However, using in vivo two photon imaging in 
the neocortex it has been shown that the cells are highly motile in this stage, actively scanning the 
environment in the healthy CNS (Nimmerjahn, Kirchhoff et al. 2005). Based on this finding, microglia 
are thought to actively survey the CNS using their processes and phagocytic activity to remove 
damaged tissues, cells and toxic substances even in the so-called ‘’resting’ state (Tremblay, Stevens 
et al. 2011; Gomez-Nicola and Perry 2015). However, beside surveillance function, microglia have 
additional functions such as contributing to brain plasticity and maintaining the integrity of the CNS 
(Lourbopoulos, Erturk et al. 2015). For example, by secreting cytokines and neurotrophic factors such 
as BDNF (Brain-derived neurotrophic factor), microglia cells increase plasticity of synapses which are 
related to learning and memory (Parkhurst, Yang et al. 2013). Furthermore, live imaging of 
fluorescent-labeled neurons and microglia has shown that microglia are in contact with synapses in 
the steady-state condition, and their contact increases when neurons are more active suggesting that 
microglia cells are important for neuronal circuitry and connectivity (Wake, Moorhouse et al. 2009). 
Using electron microscopy and two-photon in vivo imaging in the primary visual cortex, it was shown 
that microglia play a role in the remodeling of synaptic structures. Microglia processes are in contact 
with axon terminal and dendritic spine, where the synapses are located, to modify the structure of 
synapses by remodeling the extracellular environment. In addition, synaptic elements have been 
detected inside microglia in normal condition suggesting that these cells are part of the degradation 
system for elimination of synaptic components (Wake, Moorhouse et al. 2009; Tremblay, Lowery et 
al. 2010; Tremblay and Majewska 2011; Salter and Beggs 2014). Moreover, in vitro studies have 
shown that exosomes or extracellular microvesicles derived from oligodendrocyte membranes are 
exclusively internalized by microglia. In addition, when the purified exosomes were injected in the 
mouse brain they were engulfed by microglia suggesting that microglia may be responsible for the 
degradation of oligodedrogial membrane (Fitzner, Schnaars et al. 2011). Different functions of 
microglia in healthy brain are shown in figure 1.1. 






1.1.3.2 Microglia in the diseased brain 
Microglia have been considered as the brain immune cells contributing in the first line of defense in 
acute lesions and against microbes by clearing off damaged tissues and cells. These cells are involved 
in brain injuries and disorders via their phagocytic activity and neuroinflammatory responses (Banati 
2003; Nimmerjahn, Kirchhoff et al. 2005; Kettenmann, Hanisch et al. 2011). However, it is notable 
that due to the limits for distinguishing resident microglia from infiltrating cells it has not been easy 
to identify the exclusive role of microglia in disease condition. Now, an increasing number of studies 
indicate that the function of short-lived peripheral macrophages and long-lived resident microglia are 
distinguishable (Butovsky, Jedrychowski et al. 2014; Evans, Barkauskas et al. 2014; Prinz and Priller 
2014). For example, in demyelinating model such as EAE (Experimental autoimmune 
encephalomyelitis), resident microglia are thought to be protective by clearing off the debris 
whereas infiltrating macrophages appear to cause demyelination due to proinflammatory responses 
(Yamasaki, Lu et al. 2014). The expression profile of activated microglia, including proinflammatory 
Figure 1.1 Functional states of microglia in the healthy brain. Phagocytic cells remove apoptotic 
neurons and tissue debris, this function is important for high turnover of cell population and 
consequently for maintaining the CNS integrity. Microglia are also important for removing extra 
synapses by pruning axon terminal. Furthermore, microglia modulate neuronal activity at the level of 
synapses. Diego Gomez-Nicola, and V. Hugh Perry, Neuroscientist 2014; 1073858414530512. 





and anti-inflammatory cytokines and other mediators varies depending on the insult in unhealthy 
brain. The functionality of activated cells can be beneficial or detrimental (Gomes-Leal 2012; Heneka, 
Kummer et al. 2014; Perry and Holmes 2014). Neuroinflammatory responses are the main reaction of 
activated microglia in the pathology of most neurodegenerative diseases. For instance, microglia-
mediated neuroinflammation causes formation of neurofibrillary tangles, pathological hallmark of 
the Alzheimer's disease (AD). Moreover, microglial immune responses, such as IL-1β expression, are 
suggested to be sufficient for tau pathology. (Kosik, Joachim et al. 1986; Iqbal, Grundke-Iqbal et al. 
1989; Iqbal, Alonso Adel et al. 2005; Bhaskar, Konerth et al. 2010; Heneka, Kummer et al. 2014). On 
the other hand, microglia cells remove extracellular β-amyloid accumulated in AD brain (Lee and 
Landreth 2010). It has been studied that TLR4- (Toll-like receptor 4) and TNF-mediated activation of 
microglia are involved in the loss of dopaminergic neurons in the mid brain of Parkinson’s disease 
models. (McCoy, Ruhn et al. 2008; Noelker, Morel et al. 2013). 
 
1.1.4 Microglia in aging 
Considering the fact that microglia reside in the CNS during lifetime of an animal, they are 
susceptible to aging (Ajami, Bennett et al. 2007; Mildner, Schmidt et al. 2007). Therefore, an 
increasing number of studies focus on the anatomical, morphological, physiological, and molecular 
changes that microglia undergo in normal aging (Conde and Streit 2006; Wong 2013).  
 
1.1.4.1 Aging phenotype of microglia 
It has been suggested that the functionality of microglia decline during aging (Streit and Xue 2010). 
To keep the overall function, microglia are able to proliferate regionally. Therefore, in aging the 
density of microglia cells in different region of CNS increases (Mouton, Long et al. 2002; Damani, 
Zhao et al. 2011; Tremblay, Zettel et al. 2012). However, the reason for the increase in the number of 
cells during aging is not clear. (Wong 2013). In addition, the distribution of microglia in aged brain is 
regionally different (Santos, Calvente et al. 2008; Damani, Zhao et al. 2011; Tremblay, Zettel et al. 
2012). In aging, the morphology of microglia also changes; their processes are shorter and show less 
complexity so that the surface area of the cells decreases (Sierra, Gottfried-Blackmore et al. 2007; 
Damani, Zhao et al. 2011; Tremblay, Zettel et al. 2012). In addition, the morphology of microglia in 
aged human brain is considered to be dystrophic in which the processes are segmented and de-
ramified showing large swellings (spheroid) at the end. Notably,  the dystrophic changes in microglia 
are not comparable to the morphological changes that occur during microglial activation in injury 
(Streit, Sammons et al. 2004). 




1.1.4.2 Basal activation state of microglia in aging 
The phenotype of aged microglia is similar to activated cells; for example, they show hypertrophy 
and retracted processes (Sheng, Mrak et al. 1998; Miller and Streit 2007). In addition, activation 
markers such as MHCII, CD11b, and OX6 are up-regulated in aged microglia (Ogura, Ogawa et al. 
1994; Frank, Barrientos et al. 2006; Ziv, Ron et al. 2006). Increased level of inflammatory cytokines 
such as IL1β, TNF-α, IL-6 is also typical of aged microglia (Sheng, Mrak et al. 1998; Sierra, Gottfried-
Blackmore et al. 2007; Njie, Boelen et al. 2012). The increased activated basal state of microglia in 
healthy aging can explain the susceptibility of aged CNS to neurodegenerative diseases (Medzhitov 
2008).  
 
1.1.4.3 The functionality of microglia in aging 
Regarding age-related changes in the morphology and activation state of microglia it is reasonable to 
connect these alterations to possible changes in their normal tasks during aging.  The dystrophic cells 
in aged human brain showed a decline in their neuroprotective function (Streit and Xue 2009). 
Furthermore, it has been found that microglia in aged brain cannot manage their role in synaptic 
plasticity as efficient as young cells because they are in less contact with synapse and axon terminal 
(Wong 2013). In fact, this deficiency can be due to declined dynamic motility of aged microglial 
processes (Damani, Zhao et al. 2011). Aged microglia are still able to migrate toward the injured site 
through parenchyma but at a lower rate compared to young cells (Damani, Zhao et al. 2011). 
Interestingly when they proliferate, their number does not return to the original level, and their 
activation state persist long term after recovery (Ajami, Bennett et al. 2007). In other words, 
microglia in aged brain represent an enhanced priming state so that, in unhealthy brain, they are 
more responsive, and their reaction is more sustained (Sparkman, Martin et al. 2005; Conde and 
Streit 2006; Sierra, Gottfried-Blackmore et al. 2007; Sandhir, Onyszchuk et al. 2008; Wasserman, 
Yang et al. 2008; Norden and Godbout 2013). The age-related priming of microglia results from 
dysregulated balance between signals which induce activation (‘’On’’ signals) and signals that adjust 
the maintenance or reversibility of responses to the basal state (‘’Of’’ signals) (van Rossum and 
Hanisch 2004; Biber, Neumann et al. 2007; Wong 2013). For example, while the expression of TLR1, 
4, 5, 7 and CD14 is up-regulated in aging, the level of ‘’Of’’ signals such as CX3CR1 and CD200 is lower 





1.1.4.4 Why microglia become aged? 
Aged microglia have shorter telomeres in comparison with young cells; therefore, their ability for 
proliferation is limited (Flanary, Sammons et al. 2007).  In addition, the production of telomerase, an 
enzyme for extending the length of telomeres, in aged cells is low. Consequently, telomeres cannot 
be elongated in again after injury-induced replication (Flanary and Streit 2005). Replication 
senescence appears to be induced in aged microglia due to shortening of telomeres. Furthermore, an 
increased level of mitochondria DNA (mtDNA) has been detected in aged microglia and the 
respiratory chain is thought to be dysfunctional so that reactive oxygen species (ROS) are over-
produced and accumulate within the cells (Corral-Debrinski, Horton et al. 1992; Lin, Simon et al. 
2002). It has been suggested that the accumulation of ROS may result in elevated microglial 
activation during aging because ROS is important for modulation of pro-inflammatory cytokine 
production which is regulated by NF-κB-(Nuclear factor kappa-light-chain-enhancer of activated B 
cells) mediated transcription (Toledano and Leonard 1991; Nakanishi, Hayashi et al. 2011). Moreover, 
since microglia are long-lived cells and their physiological activities are sustained with time, the 
biological components accumulate within these cells. These accumulations affect the phenotype of 
the cells including morphology and activation state (Ma, Coon et al. 2013; Wong 2013). 
 
1.1.4.4.1 Lysosomal storage; Lipofuscin  
Lipofuscin is an indigestible polymeric compound which is formed in non-dividing cells such as 
neurons, retinal pigment epithelial cells (RPE) as well as microglia due to the accumulation of 
biological molecules and waste material with time (Essner and Novikoff 1960; Terman and Brunk 
1998; Brunk and Terman 2002). Lipofuscin is yellowish-brown with autofluorescent feature; it 
includes various fluorophores that can be detected across a broad spectrum (Terman and Brunk 
1998; Gray and Woulfe 2005). Lipofuscin formation is considered as lysosomal storage which is the 
main characteristic of aging phenotype since the amount of that increases with age (Strehler, Mark et 
al. 1959; Hohn and Grune 2013).  
Lipofuscin has been detected as lysosomal inclusions in microglia in the aged brain. (Peinado, 
Quesada et al. 1998; Sierra, Gottfried-Blackmore et al. 2007; Tremblay, Zettel et al. 2012). However, 
lipofuscin formation is well-known in RPE cells. Lipofuscin in RPE cells is mainly derived from 
photoreceptor outer segments (POS) in the retina (Feeney-Burns and Eldred 1983). In physiological 
condition, regularly, RPE cells phagocytose POS (photoreceptor outer segments) in a large amounts 
(Bok 1993; Strauss 2005).  Digestion of this huge amount of photoreceptors is a big challenge for the 
lysosomal system of the cells (Feeney-Burns and Eldred 1983). On the other hand, with time, the end 
products of oxidized low-density lipoproteins and lipid peroxidation, which are produced during 




normal cell metabolism, are stored within lysosomes. These metabolites reduce the degradation of 
internalized POS. Therefore, POS-derived components accumulate within the cells and facilitate the 
formation of lipofuscin (Finnemann, Leung et al. 2002; Kaemmerer, Schutt et al. 2007; Kaarniranta, 
Sinha et al. 2013). In general, it has been shown that the formation of lipofuscin is mainly due to the 
oxidative stress in the lysosomes. Under normal conditions, the internalized materials in the 
lysosomes become oxidized because of iron-catalyzed peroxidation occurring inside the lysosome. 
Consequently, they become resistant to enzymatic activity of lysosome and then indigestible. Then 
these undegradable components accumulate in the form of lipofuscin with time when the cells no 
longer divide (Terman and Brunk 1998; Boulton, Rozanowska et al. 2004; Terman, Kurz et al. 2010; 
Kaarniranta, Sinha et al. 2013). Regarding the importance of oxidative reactions for the daily life of 
cell, and the fact that a small amount of lipofuscin is also formed in young cells; therefore, oxidative 
reaction should be considered as age-independent inducer of lipofuscin formation. Age-related 
increase in autophagocytosis, decline in lysosomal activity, and decrease in exocytosis are noticed as 
age-dependent enhancer of lipofuscin (Terman and Brunk 1998). 
The accumulation of lipofuscin in the cells contributes to a decline in cell function (Neufeld 1991; 
Brunk and Terman 2002). For example, proteosomal activity is inhibited by loading cells with 
lipofuscin in vitro (Sitte, Huber et al. 2000). In addition, due to high amount of iron in lipofuscin the 
cells become more susceptible to oxidative stress which is mainly iron-mediated (Terman, 
Abrahamsson et al. 1999). The accumulation of damaged mitochondria has been detected within 
lipofuscin-loaded cells in lysosomal storage diseases. (March, Wurzelmann et al. 1995). Furthermore, 
lipofuscin accumulation in RPE cells cause the most common age-associated visual disorder, known 
as age-related macular degeneration (Katz 2002; Wolf 2003; Sparrow and Boulton 2005); also, it can 
be a risk factor for the age-related diseases such as Alzheimer’s and Parkinson disease (Adamec, 
Mohan et al. 2000; Brunk and Terman 2002; Wolf 2003; Sparrow and Boulton 2005). 
 
1.2 Myelin  
1.2.1 Myelin structure 
Myelin is composed of tightly wrapped membranes around axons and is produced by 
oligodendrocytes in the CNS (Bunge, Bunge et al. 1962). Wrapped myelin membranes along the 
length of axons are regularly spaced; this space, which is myelin free, is called node of Ranvier.  In 
fact, the compacted structure of myelin is important for the fast and saltatory conduction of electric 
signals from one node to the next.  The myelinated area between two nodes is called internode, at 




contact between axon and myelinating oligodendrocyte. The region between paranode and 
internode is called juxtaparanode (Pfeiffer, Warrington et al. 1993(Baumann and Pham-Dinh 2001). 
Myelin sheath is composed of compacted and non-compacted areas. Compacted myelin is refferd to 
closely packed membrane along the internode between inner and outer tongue with a thin 
cytoplasm. Non-compacted myelin includes paranodes, contains more cytoplasm and is important 
for transport of metabolites to the compacted area during myelin biogenesis (Quarles 1999; 
Snaidero, Mobius et al. 2014)  
 
1.2.2 Myelin composition 
While most plasma membranes are composed of 50% proteins and 50% lipids in dry weight, 73-81% 
of the total dry weight of myelin membrane is formed by lipids (Pfeiffer, Warrington et al. 1993; 
Chrast, Saher et al. 2011). About 27% of myelin lipids are glycosphingolipids including 
Galactosyceramide as well as sulfatide, and almost 16% are plasmalogens (Aggarwal, Yurlova et al. 
2011). In  addition, cholesterol is the most abundant lipid in myelin (Baumann and Pham-Dinh 2001). 
Myelin basic protein (MBP) and proteolipid protein (PLP) account for the majority of myelin proteins 
(Campagnoni and Macklin 1988). These two proteins are mainly enriched in campacted myelin 
(Bakhti, Aggarwal et al. 2014) while Neurofascin 155 and Tag1 (transient axonal glycoprotein-1) are 
typical proteins of paranodes and juxtaparanodes. Myelin oligodendrocyte glycoprotein (MOG), 
myelin-associated glycoprotein (MAG), myelin-associated oligodendrocytic basic protein (MOBP), 
and 2’, 3’-Cyclic-nucleotide 3'-phosphodiesterase (CNPase) compose the remaining part of myelin 
protein content. CNPase and MAG are found in non-compacted myelin while MOBP is included in 
compact myelin (Poliak and Peles 2003; Salzer 2003). 
 
1.2.3 Myelination in the CNS 
During development oligodendrocyte produce a huge amount of myelin membrane. One cell can 
form 20×105 µm2 surface area of myelin (Pfeiffer, Warrington et al. 1993); in addition, 
oligodendrocytes can myelinate several axons at once. In the cortex and corpus callosum one cell can 
produce between 30 and 80 internodes ranging from 20 to 200 µm in length with up to 60 different 
lamellae on several thin axons. On the other hand, larger axons are myelinated with longer 
internodes (1500 µm) and thicker myelin sheath with 150 layers (Matthews and Duncan 1971; 
Murray and Blakemore 1980; Hildebrand, Remahl et al. 1993). Oligodendrocytes are considered as 
the most efficient membrane producers. In human, during the first year of age, the majority of the 
axons become myelinated, but in some cortical areas myelination still occurs during adulthood 




(Fields 2008). Myelination in mice starts at birth and it is completed in  most areas at postnatal day 
60 (Baumann and Pham-Dinh 2001).  
 
1.2.4 Myelin turnover 
Membrane components of myelin need to be replaced continuously to maintain myelin integrity and, 
consequently, nerve conductance in the CNS. Myelination is an intensive ongoing process by 
oligodendroctytes in development and also later during adulthood (Watkins, Emery et al. 2008; 
Young, Psachoulia et al. 2013; Nave and Werner 2014), removal of modified toxic components or 
myelin disposal, produced or accumulated  during this process, is  considered as a part of myelin 
turnover. In general, myelin components have slow turnover rate. Using stable isotope-labeling and 
mass spectrometry (MS) the half-replacement time of myelin lipids was measured according to 
incorporation rate of newly synthesized molecules in adult mice. The results showed that cholestrol 
with 359 days half-life is the most stable lipid in the myelin sheath. Ganglioside GM1, cerebroside, 
phosphatidylethanolamine, and phosphatidylcholine have a half-life of  102 days, 94 days , 25 days 
and 20 days, respectively (Ando, Tanaka et al. 2003). Furthermore, using pulse-chase labeling and 
mass spectrometry in rats, some proteins of myelin sheaths including MBP, PLP, MOG and Nef3 
(Neurofilament 3)  were found in the list of long-lived proteome (Toyama, Savas et al. 2013).  
It is notable that turnover rate of myelin components can be age-related. For example, cerebroside 
and GM1 were replaced with a slightly higher rate in aged mice compared to young and adult 
animals (Ando, Tanaka et al. 2003). 
 
1.2.5 Myelin plasticity 
The concept of myelin plasticity implies that newly differentiated oligodendrocytes are added to the 
CNS due to the continuous division and differentiation of oligodendrocyte precursor cells (OPCs) 
from development to the adulthood. (Dimou, Simon et al. 2008; Rivers, Young et al. 2008; Kang, 
Fukaya et al. 2010; Zhu, Whittemore et al. 2011; Wang and Young 2014).  The newly synthesized 
myelin sheaths by adult-born oligodendrocytes are suggested to be incorporated into the pre-
existing myelin sheath through myelin sheath replacement or myelin remodeling; or they can be 
used for de novo myelination of previously naked axons (Wang and Young 2014) (Figure 1.2). 
Furthermore, it has been shown that in comparison to oligodendrocytes in development, adult-born 




axon (Young, Psachoulia et al. 2013) and the length of internodes is even more reduced in aging in 
the spinal cord of 14 and 21 months old mice (Lasiene, Matsui et al. 2009) In fact, it has been 
suggested that generation of short internodes is an  indication of de novo myelination as it happens 
during remyelination after myelin degeneration (Gledhill and McDonald 1977).  In addition, the cell 
cycle time of OPCs (NG2 expressing cells) increases with age; therefore, the proliferation rate of OPCs 
in aging is low. (Lasiene, Matsui et al. 2009; Psachoulia, Jamen et al. 2009; Clarke, Young et al. 2012; 
Young, Psachoulia et al. 2013). However, some studies have shown that the number of new 
oligodendrocytes (CC1 positive cells) increases in aged mice and also monkeys (Sandell and Peters 











1.2.6 Myelin in aging 
Age-related changes in myelin structure have been mostly studied by Peters et al. in rhesus monkeys 
(Sandell and Peters 2001; Peters and Kemper 2012). Myelin alterations during aging, which are 
considered as degeneration of myelin membrane structure, cause changes in conduction of electric 
signals between neural networks (Peters and Kemper 2012). Therefore, these changes can be the 
main reason for cognitive decline.  The most common age-dependent defect in myelin is that myelin 
layers break at the major dense line (formed by apposition of cytoplasmic faces at the edges of the 
sheet, enclosing cytoplasm within a loop (Quarles 1999)) so that an area with a dense cytoplasm 
containing lysosomes, vacuoles, and inclusions is formed. Another effect of aging is the formation of 
Figure 1.2 Potential types of myelin plasticity in the CNS in adulthood.  
Reprint by permission from Elsevier, license number: 3653661489499 
 




balloons in the myelin sheath. The size of these balloons varies from 1-10 micron; the large ones, 
basically, interfere with the loading of new formed myelin membrane in the preexisting membrane.  
It has been shown that in aging myelin formation is continuous which results in myelin redundancy 
and also the formation of thick sheath with several circuitous splits (Peters 2002; Peters 2007). Over 
25 years of age in monkeys there is a decrease in the number of nerve fibers. Moreover, due to the 
degeneration of axons in the nerve fibers some empty myelin sheaths are detected in the  primary 
visual cortex of a 13-year-old monkey (Sandell and Peters 2001; Peters 2002; Peters 2007). 
 
1.3 Demyelinating animal models 
1.3.1 Cuprizone mouse model 
 
1.3.1.1 Cuprizone-induced demyelination 
Cuprizone (bis-cyclohexanone-oxaldihydrazone) is a copper chelator. The administration of cuprizone 
in mice induce copper deficiency preferentially in oligodendrocytes and consequently demyelination. 
(Kesterson and Carlton 1971; Pattison and Jebbett 1971; Blakemore 1972). Copper is important for 
the functionality of mitochondrial enzymes including copper-zinc superoxide dismutase and 
ceruloplasmin (Walshe 1995). Therefore, it has been hypothesized that due to cuprizone-induced 
copper deficiency, mitochondrial function and consequently energy metabolism in oligodendrocytes 
is disturbed and cell death is induced (Komoly, Jeyasingham et al. 1987; Matsushima and Morell 
2001). However, why only oligodendrocytes are susceptible is not well known. It has been thought 
that due to production of massive amount of myelin, these cells are metabolically active and have an 
high energy requirement (Matsushima and Morell 2001). Feeding the mice with 0.2% w/w cuprizone 
in the food for 3-4 weeks induce demyelination mainly in corpus callosum, 5 weeks after cuprizone 
diet more than 90% of axons are affected. Interestingly, 6 weeks after treatment 50% of axons 
become remyelinated, and by removing cuprizone, remyelination occurs continuously (Matsushima 
and Morell 2001; Merkler, Boretius et al. 2005). On the other hand, increasing the duration of 
cuprizone treatment to 10-12 weeks causes ongoing demyelination so that a few myelinated axons 





1.3.1.2 Immunopathology of cuprizone mouse model 
The blood-brain barrier in cuprizone model is not breached; therefore, there are only little 
macrophages in the CNS during demyelination course. (Matsushima and Morell 2001; McMahon, 
Suzuki et al. 2002). 3 weeks after cuprizone treatment, when the demyelination is active, a significant 
number of microglia are observed mainly in corpus callosum. During 4-6 weeks of cuprizone 
exposure the number of activated cells increases (Hiremath, Saito et al. 1998). Beside possible 
infiltration of monocytes from periphery, it has been suggested that resident microglia from the 
other regions of the brain migrate to the lesion or they are locally proliferated (Matsushima and 
Morell 2001). Microglia in cuprizune-induced demyelination remove myelin debris (Smith 1999). Due 
to intact blood-brain barrier and minimal infiltration of peripheral immune cells, cuprizone mouse 
model has been considered as a suitable model to study the role of resident microglia during 
de/remyelination.  
 
1.3.2 Shiverer mouse 
Shiverer mutant mouse was first observed in the F38 generation of Swiss Vancouver stock by Biddle 
et al. (1973). Shiverer is an autosomal mouse mutation of MBP; there is no compact myelin in the 
CNS of the mouse carrying this mutation. While the normal MBP gene (32 kb) has 7 exons, 5 are 
deleted in shiverer mice and only the first two exons remain (Roach, Takahashi et al. 1985). 
Generalized tremors, seizures, and a short life span (50-100 days) are the main characteristics of this 
mutant (Chernoff 1981). Dysmyelination in these mice is not due to oligodendrocyte cell death, and 
no infiltration of macrophages has been reported (Bird, Farrell et al. 1978). The form of axoglial 
junctions in the shiverer CNS is not normally oriented because of fine tubular processes of 
oligodendrocytes around the axon. In addition, the number of these junctions increases (Rosenbluth 
1981). Furthermore, the major dense line, which is normally established by cytoplasmic leaflet of the 
oligodendrocyte membrane in myelin is absent in the mutant mice (Privat, Jacque et al. 1979).  
 
1.3.3 PLP overexpressing transgenic mice, a model for Pelizaeus-Merzbacher 
disease 
Duplication of X-linked plp1 gene (proteolipid protein gene 1) which results in overexpression of PLP 
protein is the most common cause of Pelizaeus-Merzbacher disease (PMD), a fatal leukodystrophy 
without therapeutic options (Seitelberger 1995). PLP overexpressing transgenic (PLP1 tg) mice is the 
mouse model of this disease (PMD mice). The main function of PLP is to maintain the integrity of 




myelin structure(Duncan, Hammang et al. 1987). PLP overexpressing transgenic mouse is considered 
as a non-immune mediated demyelination model in which dysmyelination starts at the optic nerve 
and spread into the brain within several months (Edgar, McCulloch et al. 2010) Oligodendrocyte 
death and axonal degeneration are other characteristics of this mouse model (Anderson, Schneider 
et al. 1998).  
 
1.3.3.1 Microglia activation in PLP overexpressing transgenic mice 
Activated microglia are found in white and gray matter very early on the 7th postnatal day, and by the 
third postnatal week microglia cells are endogenously reproduced.  Microglia produce a high level of 
TNF-α and IL-6 in this stage; in addition, CC chemokines ligands and receptors including CCL3, 4, 8, 
CCR1 and 6, and also CXCL9 and 10 are up-regulated. Since activated microglia are found when the 
myelination has not started even in normal condition, it has been then suggested that myelin 
degradation does not trigger microglia activation in plp1 tg mice. Overexpression of PLP, but not 
myelin abnormalities, is thought to be the reason for the primary immune activation.  
In PLP overexpressing transgenic mice, microglia-induced inflammation is considered to be important 
for axonal lost and disease progress (Bradl, Bauer et al. 1999; Tatar, Appikatla et al. 2010). In 
addition, short and thick processes are the common morphological features of activated microglia 
cells that are detectable in both white and gray matter when the mice are at 21 days of age. 
However, these changes are not seen in all microglia; for example, in the striatum and corpus 
callosum the processes are longer as they are in normal condition (Tatar, Appikatla et al. 2010).    
 
1.4 Endocytic pathway 
1.4.1 Endosome biogenesis 
Lysosomes are catabolic compartment in eukaryotic cells, important for degradation of internalized 
materials and also components which are processed by autophagy (Kornfeld and Mellman 1989; 
Funato, Beron et al. 1997). Many different proteins are involved in endocytic trafficking regulating 
endosome maturation, movement, fission, and fusion. Small molecular weight G-proteins called Rab 
GTPase play a major role in endocytic pathway (Zerial and McBride 2001). These proteins belong to 
the Ras suprfamily of GTPases, they are located in the cytosolic part of intracellular membranes, and 
regulate different steps in membrane traffic pathways by switching between active (GTP-bound) and 




fusion (Stenmark and Olkkonen 2001; Pfeffer and Aivazian 2004; Gurkan, Lapp et al. 2005). 11 and 60 
Rab proteins have been identified in yeast and human, respectively (Pereira-Leal and Seabra 2001). 
Rab4a, Rab5a, Rab5b, Rab5c, Rab11, Rab18, Rab22, and Rab25 are localized in the early endosomal 
compartments (Bucci, Parton et al. 1992; Lutcke, Parton et al. 1994). Rab7 and Rab9 are found in the 
late endosomal compartments (Chavrier, Parton et al. 1990; Lombardi, Soldati et al. 1993). Rab5 is 
responsible for the formation of early endosome by regulating the fusion of endocytic vesicles 
(Hutagalung and Novick 2011). When cargo is trafficked through endocytic compartments, Rab5 is 
replaced by Rab7; this switch between Rab5 and 7 mediates transformation of early to late 
endosome (Rink, Ghigo et al. 2005; Vonderheit and Helenius 2005).  
 
1.4.2 Lysosome biogenesis, Role of Rab7 
Rab7 is involved in endocytic trafficking, specifically, in trafficking of early and late endosome; Rab7 
regulates the movement of cargo out of early endosomes to late endosome (Chavrier, Parton et al. 
1990; Vitelli, Santillo et al. 1997; Vonderheit and Helenius 2005). Rab7 has also been found to be 
required for the fusion between late endosome and lysosome. Its function is also important for cargo 
transfer from late endosome to lysosome (Bucci, Thomsen et al. 2000; Vanlandingham and Ceresa 
2009). Moreover, by expressing Enhanced Green Fluorescent Protein (EGFP)-tagged wild type Rab7 
and also using dominant-negative mutant proteins it has been shown that Rab7 is required for the 
biogenesis and maintenance of lysosomal structure. In the absence of Rab7, the lysosomes cannot be 
aggregated around the nucleus so that they are diffused throughout the cytoplasm. Therefore, it has 
been suggested that Rab7 might regulate the movement of vesicles along the cytoskeleton by 
engaging motor proteins such as myosin I, kinesin, and dynein to facilitate the aggregation of 
lysosomes around the nucleus. In addition, Rab7 controls the fusion of late endocytic compartments 
by regulating tight membrane interactions. Furthermore, acidification of lysosomes, which is 
necessary for the activity of hydrolases, the main lysosomal enzymes,(Mellman, Fuchs et al. 1986) is 
disturbed in the absence of Rab7. In conclusion, Rab7 is required for function of late endocytic 
structures including endosomes and lysosomes in the perinuclear region (Bucci, Thomsen et al. 2000) 
(Fig 1.3). 
 


















1.5 Question and hypothesis of the project 
The main question of our project was how myelin molecules that are trapped within the numerous 
layers of tightly compacted membrane get access to the degradation system for myelin turnover. We 
hypothesized that myelin fragments which are formed by shedding myelin sheath in the extracellular 
space may be engulfed by microglia cell.  Furthermore, we asked how the possible interaction of 
microglia with myelin affects the cell function with time. We hypothesized that overloading 
lysosomes with myelin components might induce senescence phenotype in microglia.  
 
Figure 1.3 Rab proteins involved in endocytic pathway. Rab5 mediates the fusion of early 
endososmes, and the exchange between Rab5 and Rab7 leads to the transformation of early 
endososme to the late compartment. Rab7 is involved in downstream endocytic pathway, 
required for cargo transfer from early endosome to late endosome as well as for the fusion 
between late endosome and lysosome. Cargo transfer from endosomes to the Golgi complex is 
also carried out by Rab proteins, such as Rab9. Reprint from Wikipedia, Created by Matthew R G 














Table 2. 1 Primary antibodies list 
Targen antigen Host species Clone Dilution Company 
Iba1 Rabbit - 1:1000 Wako 
MBP Mouse SMI94 1:1000 Covance 
MBP Rabbit - 1:500 Dako 
Mac2 (Galectin 3) Rat M3/38 1:200 Biolegend 
MHCII Rat M5/114.15.2 1:200 eBioscience 
LAMP1 Rat 1D48 1:200 
Santa Cruz 
Biotechnology 
CR3/Mac1/CD11b Rat - 1:200 Bio-Rad 
Mac3 Rat M3/84 1:200 BD Pharmingen 
CD45 Rat - 1:200 Bio-Rad 






All biotinylated secondary antibodies (IgG) for DAB staining were purchased from Vector 
Laboratories. Fluorescence secondary antibodies including Alexa Fluor 488, 555, 647, Cy3 and Cy5 
were purchased from Dianova and Invitrogen. Streptavidin-conjugated Alexa Fluor 488 was from 
Invitrogen. Anti-mouse and anti-rabbit horse radish peroxidase (HRP)-conjugated secondary 
antibodies used for Western blot were from Dianova. 
 




2.1.2 Commercial kits 
 
Table 2.2 List of commercial kits 
Kit  Application  Company 
Spin Tissue Midi Kit  DNA extraction for genotyping Invitek 
NucleoSpin RNA XS total RNA isolation Macherey-Nagel GmbH & Co.KG 
Neural Tissue Dissociation Kits Microglia isolation Miltenyi Biotec  
 
2.1.3 Primers 
All the primers were synthesized by ACGTLab, DNA core facility at Max Planck Institute for 
Experimental Medicine, they are listed as following: 
 
Table 2.3 list of primers 
Primer ID Sequence  description  
25174 5'-CAC GGG GGA GGC AGA GGG TTT-3' Fwd for E2A Cre; Neo   
25175 5'-GCG GAG CAC GGG CCA CAT TTC-3' Rev for E2A Cre; Neo   
26230 5'-AGATGACGTAGTTTTCGCGCTT-3' Fwd for Ella promotor  
17411 5'-TCCGGTTATTCAACTTGCAC-3' Rev for ParvCRE 
24050 5'-TATCTTCTATATCTTCAGGCGC-3' Fwd for CX3CR1 Cre ERT2  
24051 5'-GTGAACGAACCTGGTCGAAATCAG-3' Rev for CX3CR1 Cre ERT2  
24052 5'-CTCACTCACTCCTAAATGG-3' for wild type Rab7 allele 
24053 5'-TTAGGCTGTATGTATGTGC-3' for Floxed Rab7 allele 
21027 5'-TACGGCATGGACGAGCTGTACAAGTAA-3' Fwd tdTomato 
21028 5'-CAGGCGAGCAGCCAAGGAAA-3'  Rev tdTomato 
29421 5'-GGAATCGGACGTCTCTGTTG-3' Fwd for amplification of Rab7 cDNA 
29422 5'-AGTCCCCCAGGATGATGAC-3' Rev for amplification of Rab7 cDNA 
1879 5'-ATGTATGTGTGTGTGTGCTTATCTAGTGTA -3' Shiverer-Fwd 
1880 5'-CAGGGGATGGGGAGTCAGAAGTGAG -3' Shiverer-Rev 
1873 5'-CCCCGTGGTAGGAATATTACATAAC -3' Wild type for shiverer detection-Fwd 








In this study the following software were used for primer design, data acquisition, and image 
processing and analysis. 
 
Table 2.4 List of Softwares 
software application source  
Imag J Image processing  http://imagej.nih.gov/ij/ 
Imaris  Image processing and analysis  Bitplane 
Adobe Illustrator CS4 Image processing Adob System Inc. 
ApE DNA editing and analysis Wayne Davis, University of Utah 
GrafPad Prism 




EndNote   Bibliography management Thomas Reuters 
Leica Confocal 
Software  
Confocal images acquisition  Leica Microsystems, Mannheim, Germany 
 
2.1.5 Solutions and Media 
 
In this study some solutions or media were commercially available, and some were manually 
prepared as described below: 
Table 2.5 Commercial components and media 
Media  Copmany  
DMEM for Primary cell culture Gibco/Invitrogen 
Fetal Calf Serum (FCS)  PAA 
GlutaMAX™-I supplement Gibco/Invitrogen 
Penicillin/Streptomycin (Pen/Strep) 100 Gibco/Invitrogen 
Protease inhibitors cocktail  Sigma 
1X PBS Gibco/Invitrogen 
1X HBSS Gibco/Invitrogen 
Power SYBR Green PCR master mix (2X) Invitrogen 
Trypsin  Invitrogen 
 
10X PBS (phosphate buffered saline): 
80 g         NaCl 
2 g            KCl 
18.05 g    Na2HPO4 _ 2H2O) 
2.4 g         KH2PO4 
Dissolved in 1 L distilled H2O. PH was adjusted to 7.4. 




2.1.6 Mouse lines 
The following mouse lines were used and analyzed in this study:  
 
Table 2.6 List of mouse line 








 Dr. Steffen Jung, Department of Immunology, Weizmann Institute of Science 
tdTomato reporter The Jackson Laboratory, Stock Number: 007905  




 The Jackson Laboratory, Stock number: 005550 
Plp1-overexpressing transgenic mice Klaus-Armin Nave, Department of Neurogenetics,  
 
Max Planck Institute of Experimental Medicine, Göttingen, Germany.  
CX3CR1 
GFP/+
 Klaus-Armin Nave, Department of Neurogenetics,  





2.2.1 Generation and characterization of conditional Rab7 KO mice 
 
2.2.1.1 Generation and breeding of mutant mice 
In order to block lysosomal degradation system in microglia, we took advantage of Cre-lox 
recombination system and the following strategy was performed. A mouse line carrying Rab7 allele 
flanked by loxP sites (Rab7flox/flox, from Dr. Aimee Edinger, Department of Cell & Developmental 
Biology University of California, Irvine), and the mice carrying a tamoxifen inducible Cre recombinase 
(Cre-ERT2) in CX3CR1 locus (from Dr. Steffen Jung, Department of Immunology, Weizmann Institute 
of Science) were used. In the latter mouse line the expression of Cre recombinase is derived by 
CX3CR1 promoter which is specifically expressed in microglia. In these mice the Cre-ERT2 along with 
a loxP-flanked neomycin resistance cassette replaces CX3CR1 exon 2 (Fig 2.1). For details of targeting 
and deleted region in the CX3CR1 locus see (Jung, Aliberti et al. 2000). To remove the Neomycin 
resistance cassette from CX3CR1CreERT2-neo locus through Cre-mediated excision, the mice carrying Cre 




oozyte stage onwards, and in all cell types (Deleter-Cre) (The Jackson Laboratory, B6.FVB-Tg(EIIa-cre) 
C5379Lmgd/J, Stock number: 003724). In the obtained chimeric mice (CX3CR1+/CreERT2-neo; Ella+/Cre), 
due to Cre recombination mediated by Ella-Cre, the floxed neomycin cassette was excised but not 
with 100% efficiency. Therefore, removal of neo cassette was confirmed by doing a PCR using 
following primer pair, 5'-CACGGGGGAGGCAGAGGGTTT-3'; 5'-GCG GAGCACGGGCCACATTTC-3' which 
results in amplification of a 500 bp fragment indicative of CX3CR1+/CreERT2 locus without neo cassette, 
and a 1800 bp product specific for CX3CR1+/CreERT2 locus with neo cassette. To remove Ella-Cre locus 
from the chimeric mice with excised neo cassette, these mice were mated with C57BL/6J wild type 
mice. PCR reactions were done using two set of primers as follows: sense Ella promoter (P1): 5'-
AGATGACGTAGTTTTCGCGCTT-3'; antisense Cre (P2): 5'-TCCGGTTATTCAACTTGCAC-3', and P3: 5'-
TATCTTCTATATCTTCAGGCGC-3'; P4: 5'-GTGAACGAACCTGGTCGAAATCAG-3'. The combination of P1 
and P2 amplified a 387bp product specific for EllaCre locus, and the mix of P3 and P4 produced a 
223bp fragment for CX3CR1Cre ERT2 locus. In this step, we got CX3CR1+/CreERT2 mice. 
To obtain double transgenic mice (CX3CR1+/CreERT2 ; Rab7flox/flox )two sets of breeding was arranged 
with CX3CR1+/CreERT2 and  Rab7flox/flox mice. For genotyping the offspring of these breeding sets two 
distinct PCR reactions using the combination of P3 and P4 and the following primer pair were done: 
wild type Rab7 allele: 5'-CTCACTCACTCCTAAATGG-3'; Floxed Rab7 allele: 5'-
TTAGGCTGTATGTATGTGC-3'. PCR products amplified by the latter primer pair were a 550 bp band 
specific for wild-type Rab7 and a 580 bp band representing floxed Rab7 allele (2 Lox: floxed allele 
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Figure 2.1 Targeted disruption of the CX3CR1 locus in mouse 




2.2.1.2 Tamoxifen induction of conditional deletion of Rab7 gene  
Double transgenic mice (CX3CR1+/CreERT2 ; Rab7flox/flox) were injected with tamoxifen at 3 weeks of age 
,as described below, to induce conditional deletion of Rab7 in microglia of these mice and obtain 
conditional Rab7 knockout mice. Control mice of the same genotype received corn oil vehicle only. 
 
Tamoxifen preparation and administration 
The animal treatment with tamxifen was approved in advance by the Lower Saxony state authorities 
(“Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit”; Postfach 39 49; 
26029 Oldenburg). The Approval ID is: 33.14.-42502-04-117/09. Tamoxifen (Sigma T5648) was freshly 
prepared the day before injection. It was dissolved in filter-sterilized corn oil to make solution of 10 
mg/ml. The solution was protected from light, and placed on the roller mixer to be dissolved over 
night at 37°C. Tamoxifen was administrated via intraperitoneal injection once every 24 hours for a 
total of 5 consecutive days. The injection dose was determined by weight, using approximately 75mg 
tamoxifen/kg body weight. For adult mice, a standard dose of 100μl tamoxifen/corn oil solution was 
effective to induce cre recombinase activity. 
 
2.2.1.3 Detection of Cre recombinase activity using reporter mice 
To test the activity of Cre recombinase in microglia, CX3CR1+/CreERT2 ; Rab7flox/flox mice were crossed to 
reporter mice carrying tdTomato gene which is  located downstream of a loxP-flanked STOP cassette. 
The offspring of this breeding, CX3CR1+/CreERT2 ; Rab7flox/+; tdTomato+, was injected with Tamoxifen at 
3 weeks of age as the same procedure described previously to drive the translocation of Cre 
recombinase to the nucleus, where it is able to delete the floxed STOP cassette, and result in 
tdTomato expression. One week after Tamoxifen injection the expression of tdTomato gene in 
microglia was confirmed by immunohistochemistry.   
 
2.2.1.4 Cre recombinase-mediated deletion of Rab7 gene in microglia  
To confirm deletion of Rab7 gene mediated by CX3CR1-driven expression of Cre recombinase, one 
and six weeks after Tamoxifen injection microglia cells from double transgenic mice (CX3CR1+/CreERT2 ; 




cells; cDNA was synthesized, and Rab7 gene expression was quantified using real-time PCR as will be 
described later. 
 
2.2.1.5 Genotyping  
The genomic DNA was extracted from the lysate of a small piece of mouse tail using the Invitek Spin 
Tissue Kit according to the manufacturer’s instruction. The DNA was eluted in 100µl elution buffer, 
and the concentration of DNA was defined by measuring the absorbance of double stranded DNA at 
260nm with a BioPhotometer plus spectrophotometer (Eppendorf). 0.1-1µg of DNA was amplified by 
GoTaq DNA polymerase (Promega, Mannheim, Germany).  
 
PCR master mix for a 25 µl reaction was prepared as following:      
15.35µl milli Q H20 
5µl 5X Taq buffer     
0.5 µl dNTPs (10mM, stock) 
0.5-1µl MgCl2 (25mM, stock) (The final concentration depends on the primers) 
1µl forward primer (10pmol/µl, stock)    
1µl reverse primer (10pmol/µl, stock) 
0.15µl Taq DNA Polymerase (5 units/µl) 
1µl DNA (0.1-1 µg) 




Step Temperature (°C) Time Number of cycles 












Final extension 72 5 minutes 1 




Agarose gel electrophoresis 
1% Agarose gel in 1X TAE buffer containing 1X SYBR safe DNA gel stain (10000X, stock, Invitrogen) 
was prepared. Electrophoresis was done in the Chambers assembled by the Feinmechanik Service 
Department at the Max Planck Institute for Experimental Medicine containing 1 X TAE buffer. The 
PCR products were visualized by transillumination using Intas Gel Documentation System (Intas 
Science Imaging Instruments GmbH). 
10X TAE (1 L): 
48.4 g Tris base 
11.4 mL Acetic acid 
20.0 mL 0.5 M EDTA 
Adjust to 1 L with ddH2O, pH 8.5 
 
2.2.1.6 Real-time quantitative PCR  
 
RNA Isolation 
Total RNA was extracted from isolated microglia using the Nucleospin RAN XS kit according to the 
manufacturer’s instruction, the concentration was obtained by measuring the absorbance of RNA at 
260nm using a BioPhotometer plus spectrophotometer (Eppendorf). 
Reverse transcription 
Reverse Transcription of RNA into cDNA was performed using SuperScript ® III First-Strand Synthesis 
System. The RNA/Primer mixture is as following:  
  
Component Amount 
0.2µg total RNA 
50µM oligo (dT) 
10mM dNTP mix 









The mixture was incubated at 65°C for 5 minutes then placed on ice at least for one minute. 




10X RT buffer  
25mM MgCl2 
0.1M DTT 
RNaseOUT (40 U/µl) 









Afterwards, 10 µl of cDNA Synthesis Mix was added to RNA/Primer mixture, incubated at 50°C for 50 
minutes, the reaction was terminated at 85°C for 5 minutes, chilled on ice. The residual RNA was 
digested by Riboneuclease H for 20 minutes at 37°C. cDNA was stored at -20°C for further use. 
 
Real-time quantitative PCR  
Expression levels of Rab7 in microglia isolated from adult mouse brain were measured by relative 
reverse transcriptase quantitative real-time PCR (RT-qPCR). The primers were designed with NCBI 
Primer Blast software. For each condition triplicates were used. The expression of the target gene 
was measured in relation to internal levels of GAPDH and 18srRNA as reference genes. The 
quantitative PCR was performed using SYBR Green PCR Master Mix according to manufacturer’s 
protocols. The relative change in gene expression was analyzed by ΔCt method, and normalized to 
the control samples.  
 Master mix composition:  
Component Amount 













Following adding 4 microliter of cDNA (20ng), 6µl of master mix was added into the each well of 96-
well plate. PCR was done in a light cycler 480.  
2.2.2 Histology 
2.2.2.1 Perfusion and tissue preparation 
Animals were anesthetized by intraperitoneal injection of 14% chloral hydrate, perfused 
transcardially with 4% parafolmaldehyde (PFA) using a MPII mini peristaltic pump (flow rate: 
3ml/min). After perfusion, brain tissue was post fixed in 4% PFA overnight. Then the tissue was 
cryoprotected in 30% sucrose in 1x PBS until when the brain sank (at least one day). The tissue was 
bound to the specimen block using Tissue-Tek O.C.T, frozen on dry ice, and wrapped in pre-cold 
aluminum foil. Free floating cryosections (30µm thickness) were obtained in coronal direction using 
cryostat Leica CM 1900, placed in 48-well plates containing cryopreservative solution (25% 
ethylenglycol, and 25% glycerol in 1x PBS), and stored at -20°C. 
 
2.2.2.2 Immunohistochemistry 
The following antibodies were used for immunohistochemistry: 
Primary antibodies: Iba1 (Ionized calcium binding adapter molecule 1) against ramified microglia,  
Mac2 (Galectin 3) and MHCII (major histocompatibility complex class II), Mac3, CD11b (Complement 
receptor 3 or Mac1), CD16/32 (Fcγ receptor II/III), CD45 for activated microglia, MBP (Myelin Basic 
Protein) against myelin, LAMP1 (lysosomal-associated membrane protein 1) for lysosomes (For more 
details see table 2.1).    
Secondary antibodies: For DAB staining we used goat anti rat biotinylated immunoglobulin G (1:200) 
and for fluorescent staining Alexa Flour 488, 647, and 555-conjugated antibodies were used (1:1000).  
Immunohistochemistry with Fluorescence detection 
Free floating sections were rinsed with 1x PBS containing 0.2% Tween-20 in 24-well plate. 
Permeabilization was performed in 0,5% Triton X-100, the incubation time varied from 10 to 30 
minutes depending on primary antibody. For blocking endogenous mouse tissue immunoglobulins, 
fab fragment goat anti mouse IgG (1:100) (dianova) was added for 1 hour at RT. The sections were 
washed briefly and incubated in 100% blocking solution (2.5% FCS, 2.5% BSA, 2.5% fish gelatin in 1x 
PBS) for 1 hour at RT. Primary antibodies, diluted in 10% blocking solution, were added and 




minutes, they were incubated in secondary antibodies, diluted in 10% blocking solution, for 1 hour at 
RT. The sections were washed with PBS, distilled H2O and mounted using fluorescence mounting 
medium (Dako) over superfrost plus slides. 
Immunohistochemistry with HRP-DAB detection 
3,3-diaminobenzidine (DAB) immunohistostaining was performed using VECTASTAIN® ABC Kit 
standard as following: Free floating cryosections were transferred to a 24-well plate, washed three 
times with PBS, each time 5 minutes on the shaker.  Endogenous peroxidase was blocked with 3% 
H2O2, incubated for 20 minutes at 4°C, and washed out with PBS. Then 100% blocking solution (as 
before) was added to the sections, incubated for 20 minutes at room temperature (RT). The sections 
were incubated with primary antibodies, diluted in 10% blocking solution, overnight at 4°C.  
Afterwards, the sections were washed with PBS, incubated with biotinylated secondary antibodies 
for 1 hour at RT. After washing with PBS 3 times, each 10 minutes,  AB solution containing 20µl 
reagent A (Avidin DH) and 20µl reagent B (Biotinylated Horseradish Peroxidase H) in 1x PBS was 
added to the sections and incubated for 30 minutes at RT. Following three washes, (each 5 minutes) 
staining was developed using 3,3′-diaminobenzidine (DAB) staining kit (Vectastain, Vector 
Laboratories). The incubation time varied depending on primary antibody.  DAB reaction was 
stopped with distilled water for 5 minutes on the shaker. Then sections were washed with PBS, and 
placed on super frost plus microscope slides to let them dry for 2-3 days. The sections were 
rehydrated in decreasing concentrations of ethanol, and finally in water, stained with hematoxilin for 
1 minute, and dehydrated using increasing percentages of alcohol, cleared in xylol (Chemie Vertrieb 
GmbH) and mounted with DePeX.   
 
2.2.3 Lipofuscin autofluorescent reduction 
 
2.2.3.1 Chemical treatment 
To reduce lipofuscin autofluorescent in old brain tissues after immunohistochemistry, the sections 
were removed from PBS, dipped briefly in distilled water, and treated with 10mM CuSO4 (Fisher 
Scientific; Pittsburgh, PA) in a buffer containing 50mM ammonium acetate and 100µM EDTA, pH 4.5 
for 90 min on a shaker. The sections were washed briefly in distilled water, and transferred to PBS. 
(Schnell, Staines et al. 1999) 




2.2.3.2 Dye separation 
Autofuorescent of lipofuscin was a significant problem in fluorescent microscopy. Therefore, by 
means of dye separation tool on Leica SP5 Confocal microscope the autofluorescent was treated as 
another fluorophore so that it could be removed from the specific signal. An unstained sample as a 
reference was used then the emission spectrum of lipofuscin was determined using lambda scanning 
option on Leica SP5 confocal microscope. The obtained spectrum should be saved in spectra 
database.  
To separate lipofuscin spectrum from a labeled sample (either with Alexa Flour 488 or 555) “spectral 
dye separation tool” was chosen, a region of interest (ROI) was manually drawn, the size of reference 
region was 10 in voxels. The measured emission spectrum which was displayed in a dialog box was 
added to spectra database; it was then available in the list under user. Afterwards, in the spectral dye 
separation dialog, lipofuscin spectrum was selected from the database, and by selecting “All 
channels” in “rescale box” all channels were rescaled together using the same factor, finally by 




2.2.4.1 Confocal microscopy 
In this study, laser scanning microscopy was used for image acquisition because confocal microscopy 
provides higher resolution images with less background than conventional light microscopy. Confocal 
microscopic images were taken using a Leica TCS SP5 AOBS confocal laser scanning setup (Leica 
Microsystems, Mannheim, Germany).  
2.2.4.2 Electron microscopy 
The mouse brain was fixed by transcardial perfusion using 4% paraformaldehyde and 2.5% 
glutaraldehyde in 0.1M phosphate buffer containing 0.5% NaCl. The brain was extracted, post fixed 
in the same fixative solution overnight. The tissue was sectioned into 200 micron thick vibrotome 
sections. Rostral and caudal regions of corpus callosum was cut and post-fixed in a solution of 1% 
osmium tetroxide in 0.1M phosphate buffer (pH 7.4) for 30 minutes at room temperature. Following 
washing with distilled water the sections were stained with 0.5% uranyl acetate in 70% ethanol for 
one hour, dehydrated in a serial dilution of ethanol, and cleared in propylene oxide and embedded in 




that ultrathin (60nm) cross section of midline corpus callosum could be cut using ultramicrotome. 
Ultrathin sections were collected on collodion-coated copper grids. The sample area was selected at 
low magnification of 2500x. 
2.2.4.3 In vivo time-lapse imaging   
Mice were initially anesthetized by an intraperitoneal (i.p.) injection of a mixture of dorbene (Pfizer), 
ketamine (Medistar) in 0.9 % NaCl to achieve a dose of 1 mg/kg body weight for dorbene and 100 
mg/kg for ketamine. The surgical plane of anesthesia was monitored by paw pinch reflex. Typically, 
half of the initial dose was injected i.p. every 60 min during imaging session according to the level of 
anesthesia. The eyes were protected from drying out with Bepanthen (Bayer). The hair of head was 
shaved with a small animal clipper (Pocket Pro, Wahl). Afterwards, Mice were placed on the custom-
build microscope stage and the temperature was maintained at 36-37 °C using a built-in heating 
block (Telemeter Electronic GmbH, Donauwörth, Germany). Using a rectal temperature probe 
(Telemeter Electronic GmbH, Donauwörth, Germany) the body temperature was monitored during 
imaging process. To control the breath of animal, an oxygen stream with the controlled pressure was 
transferred to a mask which was positioned in front of the snout.  The surgery got started with 
removing the skin on top of skull and cleaning skull so that it became free of hair and connective 
tissue and dry. Then a custom-built ring is fixed on the skull bone using Durelon™ Carboxylate Luting 
Cement (3M ESPE). Once the cement is completely dry and stably fixed in the setup, the bone in the 
center of the ring is thinned using a dental micromotor (FOREDOM® Electric Co.). The ring around the 
thinned area provides a waterproofed pool around the area of interest for imaging; the ring was 
filled with 0.9 % NaCl.  To acquire the images, a Laser Scanning Microscope 710 from Carl Zeiss 
equipped with a 20x Plan-APOCHROMAT water immersion objective with a high numeric aperture 
(NA 0.95) was used. A modelocked Ti: sapphire Chameleon Vision II laser system from Coherent was 
adjusted to 880 nm wavelength. Excited fluorescence was detected with nondescanned detectors 
endowed with 525/45-nm and 624/40-nm band-pass filters (Semrock, Inc.). The live imaging was 
done for 15 minutes.  
Image analysis: To quantify the dynamics of the cell process motility, time lapse movies were 
analyzed with Imaris software as following. A single process of the cells was segmented; a surface 
was created for the whole area and volume of the process. The surface with the same threshold was 
applied for the same process in the following images every 32 seconds. Using the surface, the area 
occupied by the process was measured automatically every recording period of 32 seconds. Two 
processes of 5 cells were analyzed. Finally, variance between the sizes of process area, which was 
obtained every 32 seconds, was calculated and compared between different groups.   




2.2.5 Image processing and analysis 
In this project all the Images were processed and analyzed with Imaris (64x version 7.7.1) and ImageJ 
1.41 image processing software.  
2.2.5.1 Cell counting 
To estimate the number of Iba1 positive cells, confocal stacks (step size: 0.8µm) were captured in the 
z-direction from the whole region of interest with 20X or 40X objectives of a Leica TCS SP5 confocal 
microscope. 
An area in the size of 1mm2 in the region of interest was selected, the total number of Iba1 positive 
cell bodies and as well as the number of Iba1 positive cells with internalized components (such as 
FITC-Dextran or MBP or lipofuscin) were counted using cell counter plugin in ImageJ. In addition, to 
confirm the quantification performed by ImageJ, cell counting was done automatically using Imaris 
software. Briefly, a region of interest was segmented and spots layer was created (radius scale: 8) for 
each marker (Iba1 and FITC/MBP/LF) in the corresponding channel, using those spots the cells were 
counted automatically. The colocalized spots were defined in the distance of 0.2µm (threshold 
value).  
2.2.5.2 Lipofuscin volume measurement 
To measure the size of lipofuscin within microglia, the individual cells were analyzed using Imaris 
software as following. An area the size of 1mm2 in cortical white matter as well as striatum was 
chosen and confocal z-stacks (step size: 0.8µm) were acquired with a Leica TCS SP5 confocal 
microscope (40x objective).  A three dimensional image was generated In Imaris’ Surpass view. Then 
the ‘’surface’’ option in tool bar was selected, in the third channel (Far red), a region of interest 
including lipofuscin compartment within a single cell was segmented. The threshold was manually set 
in a way to carefully cover the whole volume of compartment in the cell by creating a surface. By 
pressing the end bottom in the software the volume of lipofuscin was automatically calculated, and 
could be exported as an excel sheet. Normally, 50 single cells were analyzed. 
2.2.5.3 Microglia-myelin contact  
Confocal z-stacks (step size: 0.8µm) were taken in striatum with 40X objective of a Leica TCS SP5 
confocal microscope. Then a three dimensional image from the whole area was created using surpass 
view in Imaris software. To measure the surface area of each microglia cell in contact with myelin, 
first, a single cell, including cell body and all the processes in total focus, was segmentad then by 
choosing ‘’spots’’ option in tool bar and adjusting the appropriate threshold, the whole cell was 




segmented; by activating the ‘’Surface’’ item in tool bar a surface was created over that area. Total 
number of spots (representing cell process or cell body) and also number of close spots to the 
surface (representing myelin) was calculated using distance threshold 0.4. Finally, using these 
numbers the percentage of cell area in contact with myelin was calculated. 
 
2.2.6 Isolation of lysosomal inclusions from microglia 
Nukina and Ihara in 1985 described a protocol, based on ultracentrifugation and detergent (Sarkosyl) 
insolubility, to isolate protein aggregations such as tau paired helical filaments form Alzheimer’s 
disease brain as well as indigestible lysosomal inclusions such as lipofuscin accumulated in aged 
brain. Therefore, in this project, we used the same protocol to isolate the lysosomal inclusions from 
microglia cells in aged mice for biochemical analysis. To do that, first we isolated microglia from old 
mouse brain. 
2.2.6.1 Microglia isolation 
For optimal dissociation of tissue samples, brain tissue from 12-month-old C57Bl/6 wild type mice 
was dissociated using a Neural Tissue Dissociation Kit (Papain) (Miltenyi Biotec). Briefly, the mouse 
was perfused by cold 1x PBS, the brain was taken out and cut into small pieces then the tissue got 
dissociated using enzyme mix 1 containing papain for 15 minutes at 37°C, and enzyme mix 2 for 10 
minutes at 37°C. Afterwards, the tissue was dissociated mechanically by wide and narrow-tipped 
pipettes until no tissue pieces remained. The suspension was applied to a 40µm cell strainer, and 
washed twice with Hank’s balanced salt solution (HBSS). To remove myelin, the tissue pellet was 
resuspended in 37% Percoll (Sigma) and overlaid on 70% Percoll in DMEM containing 2% FCS (Fetal 
Calf Serum), centrifuged at 500g for 30 minutes with no break. A thick myelin fraction which was 
formed over 37% percoll gradient was totally removed using vacume pump. A Thin fraction, 
containing single cell suspension, in the interface between 37% and 70% percoll was then carefully 
taken out and washed with the medium and MACS rinsing solution (0.5% BSA and 2mM EDTA in PBS 
1X). Microglia were then isolated from that single-cell suspension by MACS® Technology. The 
suspension was incubated with CD11b (Microglia) MicroBeads (Miltenyi Biotec) at 4°C for 15 
minutes, after washing with MACS rinsing solution, the pellet was resuspended in 500µl of the same 
buffer, applied on a MACS column placed in the magnetic field, following three times wash with 
500µl MACS buffer, CD11b positive cells (microglia) were then flushed out of the column, centrifuged 
at 400 x g for 8 minutes at 4°C. The pellet was resuspended in 1ml 1x PBS and washed one more 
time. The final pellet was flash frozen in liquid nitrogen, and stored at -80°C for future use. 




2.2.6.2 Sarkosyl-insoluble fractionation of microglia  
The final pellet containing 1.5×106 isolated microglia cells of 12-month-old mice was rsuspended in 
PBS, and divided into two portions. One part, called cell lysate, was prepared to be used directly for 
western blotting later. The other part was used for Sarkosyl-insoluble fractionation, resuspended in 
300µl 10% sarkosyl and 1µl of 10µg/ml β-mercaptoethanol and incubated at 4°C for 4 hours on a 
roller. Afterwards, to separate Sarkosyl-insoluble fraction of the cells, the solution was transferred in 
Beckman 1.5ml tubes, and centrifuged at 130000 x g for 35 min at 4°C. The pellet was resuspended in 
1ml cold 1x TBS (50mM Tris pH 7.6, 150mM NaCl) and, centrifuged again at 130000 x g for 35 min at 
4°C. The resulting pellet was washed one more time in cold 1x TBS. the supernatants was removed 
carefully and the final pellet (Sarkosyl-insoluble fraction, SIF) was flash frozen and stored at -80°C for 
further use.  
To examine the solubility of myelin membrane in Sarkosyl, the same experiment was done with 
1.5µg pure myelin membrane isolated from 2 months old wild type mice as following.  
 
2.2.6.3 Myelin isolation and purification 
The myelin from 8-week-old C57BL/6 mice brains was isolated by sequential centrifugation on 
discontinuous sucrose gradient according to a protocol previously described (Norton and Poduslo, 
1973) with some modifications. The ultracentrifugation was done using SW41 Ti rotor. The brain 
tissues were homogenized with a Dounce homogenizer in a solution containing 10mM HEPES, 5mM 
EDTA, 0,3M sucrose, and protease inhibitor. The homogenized tissue was layered on a sucrose 
gradient composed of 0,32M and 0,85M sucrose prepared in 10mM HEPES, 5mM EDTA. (pH 7,4), 
centrifuged at 75000g for 30 minutes with low deceleration and acceleration. The crude myelin 
fraction was removed from interface, resuspended in distilled water, and centrifuged at 75000g for 
15 minutes. The pellet was subjected to two rounds of hypo-osmotic shock by resuspension in 10ml 
ice-cold water, centrifuged at 12000g for 10 minutes. For purification of myelin, the pellet obtained 
from the last step was dissolved in HEPE/EDTA buffer, and placed over the sucrose gradient; all the 
centrifugation steps and hypo-osmotic shocks were repeated as before. Eventually, the purified 







2.2.6.4 Western blotting 
SDS-PAGE 
To detect proteins in isolated sarkosyl-insoluble fraction (lipofuscin), sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) was performed as described previously.  
(Burnette,1981; Laemmli, 1970Natalia thesis). 12% two-layer gel was prepared with Bio-Rad Mini- 
PROTEAN 3 casting system as following:  
Stacking gel (10 ml) 
  
Component Amount 
30 % Acrylamide/bis-acrylamide 
0.5M Tris-HCl pH 6.8 
10% SDS 
10% ammonium persulfate (APS) 









Resolving gel (12 %) (10ml) 
  
Component Amount 
30 % Acrylamide/bis-acrylamide 
1.5M Tris-HCl pH 8.8 
10% SDS 
10% ammonium persulfate (APS) 









The resolving gel was poured to 2/3 height of casting system, the remaining part of system was filled 
with isopropanol to ensure a horizontal interface. After polymerization, isopropanol was removed, 
the stacking gel was added and a comb was adjusted.  
The equal volume of all protein samples were dissolved in protein sample buffer (see below) and 
boiled at 90°C for 5 min to denature proteins. 




Protein sample buffer 6X: 













ddH2O   2.1ml 
 
The gel cassette was adjusted into a clamping frame, placed in the tank filled with PAGE buffer (see 
below). 15µl of sample was loaded onto the gel and the electrophoresis was performed with 100 
voltages. 
PAGE buffer 
0.25 M Tris base 
1.92 M Glycine 
1 % SDS 
Western Blot 
After electrophoresis, western blot was performed to detect MBP in the cell lysate, Sarkosyl-
insolubel fraction of microglia cells and pure myelin membrane using a polyclonal MBP antibody. 
After separation with SDS-PAGE, the proteins were transferred from the gel onto the nitrocellulose 
membrane using the mini Trans-Blot Module. The gel sandwich in blotting cassette was set up and 
placed in the tank of the module containing transfer buffer (0.25 M Tris base, 1.92 M glycine, 20 % 
methanol) and applied with 100 V for 1 hr. 
Afterwards, the membrane was washed in PBST (0.1 % Tween 20 in PBS) for 10 min, immersed in 4 % 
skim milk powder in PBST as a blocking solution for 30 min at RT and then incubated with primary 
antibody in PBST at 4°C overnight. After washing the membrane 3 times, each 10 min, with PBST, it 
was incubated with horse radish peroxidase (HRP)-conjugated secondary antibody in PBST for one 
hour at RT. Then targeted protein was detected with enhanced chemiluminescence method using 
equal volumes of Luminol enhancer and peroxide solutions (Pierce/Thermo Scientific) covering the 





2.2.7 In vivo endocytosis assay 
Mice were anesthetized intraperitoneally with a solution (0.15ml/25g) containing 4% Rompun™ 2% 
(xylazine) (Bayer DVM for veterinary professionals) and 12.5% ketamine 10% (Medistar) in 0.9% NaCl, 
placed into stereotaxic apparatus (Kopf Instruments), and 1.5µg FITC-conjugated Dextran  (40kDa; 
Molecular probes, Eugene, OR, USA) in sterile PBS 1x was injected by a glass capillary microinjector at 
the following coordinates relative to bregma: 0.3mm anterior, 1.2 mm lateral and 1.2 mm below 
cortical surface. 7 hours after injection the mice were perfused and the brain tissues were prepared 
and stained as described before. 
2.2.8 Cuprizone treatment 
Six weeks after tamoxifen injection, Rab7 conditional knockout mice as well as corresponding control 
mice were treated with 0.2% cuprizone for four weeks to complete demyelination course in the 
central nervous system, following that the animals received normal diet for another four weeks to 
induce remyelination. Some groups were fed with the normal food 5, 11, 19, and 33 weeks after 
completed remyelination (recovery). Age-matched controls received normal diet without cuprizone 
throughout the whole experiment.  
2.2.9 Ethics Statement 
 All experiments were approved and conducted in accordance with animal protection laws approved 
by the Government of Lower Saxony, Germany. The Approval ID is 33.7-42502-04-12/0778. C57BL/6 
mice were used for all experiments. They were kept in groups of three in standard plastic cages and 
maintained in a temperature-controlled environment (21 ± 2°C) on a 12-h light/dark cycle with food 
and water available ad libitum. 
2.2.10 Statistics  
Statistical analysis was done using GraphPad Prism (GraphPad Software, Inc.). To compare two 
groups, a Student's t-test was used. One-way ANOVA was performed for comparison of more than 
two groups. A p value of <0.05 was considered significant in all the tests. All values are represented 









In this study we tested the possibility that microglia are involved in normal turnover of myelin during 
aging.  
3.1 Myelin breakdown during normal aging   
The brain tissues from 7 and 18 months old mice were prepared for electron microscopy as 
previously described. Myelin fragments were detected in extracellular space and also inside the cells 
in the white matter including corpus callosum and cortical white matter. Quantification of the 
number of extracellular myelin fragments in different age groups showed a significant increase with 
time. 
 
3.2 Microglia are involved in myelin turnover in normal aging 
3.2.1 Microglia are in contact with myelin in wild type mice 
To visualize microglia and compact myelin in the parenchyma, we used Iba1 and MBP antibodies, 
repectively, the brain slices of wild type mice at 2, 4, 9, 18, and 24 months of age were used for 
histological studies to assess the contact of microglia with myelin. Confocal imaging of 18 and 24 
months old mice showed that microglia form contact with myelin fragments via their processes. 
Figure3.1 Myelin fragments during normal aging in wild type mice. A) Electron microscopy 
images from an 18-month-old mouse showing myelin fragments in different positions: (a) in the 
extracellular space, (b) inside the cell, (c) a myelin fragment tearing away from the axon (d) a 
myelin fragment being engulfed by a cell, and. Scale bar: 2000nm. B) Quantification of myelin 
fragments number in 7 and 18 months old wild type mice. There is an increase with tim. Mean 
value+SD were indicated. **p<0,05. Student’s t-test. 
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In addition, we quantified the size of microglia-myelin contact by measuring the cell surface area in 
contact with myelin using Imaris software as previously described. The size of contact was quantified 
mainly in striatum where the processes of microglia were more in focus due to less compaction of 
myelin compared to corpus callosum. The results showed that with age the size of cell area in contact 
with myelin significantly increased. (Fig. 3.2)  
 
3.2.2 Myelin fragments are engulfed by microglia  
Using immunohistochemistry myelin fragments labeled with MBP were detected at 18 and 24 
months of age of wild type mice. These fragments which were mainly observed in cortical white 
matter and striatum but less in the corpus callosum were found within microglia at the age of 18 and 
24 months. (Fig. 3.3) 
Figure3.2 Microglia are in contact with myelin in normal aging.  Microglial and compact myelin in 
the striatum of 2, 4, 9, 18, and 24 months mice were labeled using Iba1 (red) and MBP (green) 
antibodies; confocal images were captured by acquiring Z-stacks. A) Confocal image from striatum in 
18 months old wild type mice, Scale bar: 30µm. a-c) the myelin fragments (Labeled with MBP in 
green) in myelinated areas are detected in close contact with the processes of microglia (Labeled 
with Iba1 in red). (d) and (e) 3D reconstruction of a microglia cell in contact with a myelin fragment. 
Scale bar: 2µm. (C) Quantification of contact size of microglia with myelin is shown as mean + SEM 
(n=4). The bigger contact size was detected in 9 months of age in wild type mice. Statistically 
significant differences are indicated by asterisks (***p<0.0001). There is no significant difference 







3.2.3 Density and lysosomal activity of microglia cells increase in the white 
matter  
Regarding the regional difference in microglia phenotype in the central nervous system in adult 
mouse (Hart, Wyttenbach et al. 2012), we focused on changes in microglia phenotype in white 
matter in normal aging. We considered the size of lysosomes as an indication of lysosomal activity in 
microglia. The brain tissues from 2, 4, 7, 9, and 24 months old wild type mice were co-labeled by Iba1 
and LAMP1 antibodies; a series of z-stack confocal images within 30µm volume of brain slice was 
acquired and the volume of lysosomes were measured with Imaris software. Enlarged lysosomes 
were detected in microglia from 7 months of age whereas in 2 and 4 months old mice there was 
almost no LAMP1 positive microglia. (Fig. 3.4 A and B). Furthermore, variation in size of lysosomes in 
white matter versus gray matter was analyzed by measuring the volume of lysosomes within 
microglia in 7, 9, and 24 months old animals. In all groups there was a significant increase in the size 
of lysosomes in the white matter in comparison to gray matter (Fig. 3.4 C). These results are 
consistent with previous work that has shown an increase in the number of ED1 positive microglia in 
corpus callosum with age (Hua, Schindler et al. 2012).  
We labeled microglia cells with Iba1 using DAB staining in wild type mice at the age of 2, 9, 18, and 
24 months old and counted the cells exclusively in corpus callosum (size of area=0.3mm2) of 5 
animals in each group. The number of Iba1 positive cells in corpus callosum was significantly higher in 
Figure 3.3 Engulfment of myelin fragments by microglia in normal aging. A) Confocal image of the 
striatum of a 24-month-old mouse. Scale bar: 30µm. (a-e) A microglia cell with internalized myelin 
fragment. (d) 3D reconstruction showing the myelin fragment inside the cell. Scale bar: 2µm. (e) 3D 
reconstruction of the same cell in a rotated position. Scale bar: 1µm. C) Quantification of the number 
of cells with internalized myelin fragment. n=3,  Mean+SD was reported, *p<0.05. Student’s t-test. 
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18 and 24-month-old mice compare to 2 and 9 months old (Fig 3.4.D) as shown previously (Mouton, 
Long et al. 2002; Hua, Schindler et al. 2012; Poliani, Wang et al. 2015) 
. 
Figure3.4 Density and lysosomal size of microglia cells increase in white matter A) Visualization of 
LAMP1 (red) positive microglia (Iba1, green) in wild type mice. Lysosomes are not detectable within 
microglia in 4 months old mice. Lysosomes are observed in microglia at 7, 9, and 24 months of age. 
Scale bars: 20µm (overview) and 7µm (zoom in). B) Quantification of the number of lysosome 
positive cells at different age of wild type mice. C) Quantification of lysosome size in white matter 
versus gray matter. The size of lysosomes which were labeled by LAMP1 antibody was quantified by 
measuring the volume using Imaris software. In 7, 9, and 24 months old wild type mice the volume of 
lysosomes in white matter compared to gray matter was significantly larger. D)  Quantification of cell 
number in corpus callosum of young, middle aged and aged wild type mice showed a significant 
increase in the number of cells with age. The statistics were done by  t-test and one-way ANOVA. *p 






3.2.4 Phagocytic activity of microglia in white matter of wild type mice 
 We analyzed the expression level of galectin 3/Mac2, a galactose binding lectin, which is known to 
be upregulated in demyelination areas and involved in myelin phagocytosis (Smith 1999; Smith 
2001). Mac2 antibody was used in DAB staining for labeling microglia in the stage of phagocytic 
activity on the brain tissues of 2, 4, 7, 9, 18, and 24 months of age. Surprisingly, Mac2 positive 
microglia were detected only in aged (18 and 24 months old) mice but not in earlier time points. In 
addition, in these mice Mac2 positive populations were found mainly in myelinated areas including 
corpus callosum, anterior commissure, and medial septal nucleus (Fig. 3.5).  
 
3.3 Cellular phenotypic alterations of microglia with age 
An increasing number of studies have shown that with age the functionality of microglia is impaired. 
Some changes in morphology and phenotype of microglia are listed in table 3.1 (Luo, Ding et al. 2010; 
Damani, Zhao et al. 2011; Hart, Wyttenbach et al. 2012; Harry 2013; Wong 2013). In this project we 
studied microglial characteristics in young (2 months old) and aged (18 or 24 months old) wild type 
mice to test whether myelin uptake by microglia during normal aging drives age-related alterations in 
the cells.  
 
Figure 3.5 Detection of galectin 3/Mac2 positive microglial population during normal aging in wild 
type mice.  Histological analysis of brain tissue of 24-month-old wild type mice using DAB staining 
showing a particular subtype of microglia which are galectin 3/ Mac2 positive and located in 
myelinated area including corpus callosum (a), anterior commissure (b) and medial septal nucleus 
(c). These cells were not detected in young and middle aged mice. Scale bars: 500µm (overview); 
50µm (zoom in). 
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Table 3. 1 characteristics of aged microglia 
Intracellular accumulation of lipofuscin 
retracted processes with less branches 
Increased activation state 
Decreased clearance function 
Decrease in motility of processes 
 
3.3.1 lipofuscin granules accumulate within aged microglia  
Intracellular lipofuscin accumulation is a hallmark of microglia aging in the retina as well as brain, and 
studies on retina have shown that the amount of lipofuscin in RPE cells  increases with age (Sierra, 
Gottfried-Blackmore et al. 2007; Tremblay, Zettel et al. 2012; Wong 2013). In our project we 
visualized and quantified the amount of lipofuscin within microglia in wild type mice. Images from 30 
micron brain slices, labeled with Iba1 using immunohistochemistry, were captured. To visualize 
lipofuscin we took advantage of autofluorescent feature of lipofuscin. Regarding the  broad range of 
excitation and emission spectra for lipofuscin (excitation: 436-650,emission 450-700nm)(Barden 
1980; Dowson 1982; Dowson, Armstrong et al. 1982; Sparrow and Duncker 2014), we found that 
when the brain tissue was excited at 633nm the strongest autofluorescent signals from internalized 
lipofuscin was generated so that we could capture the images in far red channel (emission 
wavelength: 650-750nm) and used them for all the analysis. We measured the volume of lipofuscin 
within microglia using Imaris software The quantification showed a significant increase in the 
quantity of lipofuscin with time.  
 
Figure3.6 visualization and quantification of lipofuscin granules in wild type mouse brain. A) 
Confocal images from wild type brain tissue shows intracellular lipofuscin (gray) in microglia (red) in 
18 months old wild type mouse. Autofluorescent signal from lipofuscin was captured by excitation at 
633nm in far red channel. Scale bar: 20µm B) Quantification of lipofuscin volume in 2, 9, and 24 







3.3.1.1 The amount of lipofuscin in white and gray matter in aged wild type mice 
To test whether intracellular lipofuscin might contain remnants of internalized myelin membrane, we 
compared the amount of lipofuscin in white matter versus gray matter in 9, 18 and 24 months old 
wild type mice. Confocal z-stack images in withe matter including striatum, corpus callosum and 
cortical white matter and in cortical gray matter including layer I and II were captured. Then the 
volume of intracellular lipofuscin in 40 single microglia in both regions was quantified using Imaris 
software. Three mice were evaluated per age group. In the mice of each group, the size of lipofuscin 





3.3.1.2 Detection of myelin fragments within lipofuscin 
Given that myelin is engulfed by microglia during normal aging, and that lipofuscin accumulates 
within microglia with age, we hypothesized that lipofuscin might contain remnants of myelin with 
time. To test this, brain tissues from 18 months old mice were labeled with Iba1 and MBP. To 
visualize myelin overlapping with lipofuscin in separated channels we needed to remove 
autofluorescent signal produced by lipofuscin in green channel where MBP was captured. Therefore, 
we did dye separation using Leica software as previously described so that lipofuscin signal was 
exclusively captured in the far red channel. However, due to broad range of emission spectrum of 
lipofuscin we were not able to eliminate autofluorescent signal of lipofuscin from the red channel 
(Em: 570-630nm). Therefore, we used this channel for detection of Iba1 signal. Using this strategy we 
could detect myelin fragments (in green Channel) associated with lipofuscin (in far red channel) 
within microglia. The volume which was labeled with MBP overlapped with the volume occupied by 
lipofuscin in the cell. (Fig 3.8 A) We also labeled myelin with green Fluoromyelin (FM) and applied the 
same strategy as above. 3D reconstruction showed that internalized myelin fragments labeled with 
FM is partially included in intracellular lipofuscin (Fig 3.8 B). We also quantified the number of cells 
Figure 3.7 Lipofuscin amount in white and gray matter in aged wild 
type mice. Quantification of lipofuscin amount in white matter 
versus gray matter indicates a significant increase of lipofuscin in 
withe matter in aged mice. Mean value+SD was reported, 
***p<0,001, Student t-test.  
3.3  Cellular phenotypic alterations of microglia with age 
42 
 
with internalized myelin within lipofuscin in 18 and 24 months old mice, and found out that the 
association between myelin and lipofuscin increases with time (Fig 3.8 C).  
 
 
3.3.1.3 Biochemical characterization of lipofuscin contents 
To analyze myelin membrane remnants in lipofuscin we isolated and analyzed their content 
biochemically by Western blotting. For this, we isolated microglia from 12 months old mice (pooled 
from 8 mice) using neural tissue dissociation kit and MACS technology. The obtained pellet of the 
pure microglia cells at this stage was divided into two parts. One part used directly for Western 
blotting to define the amount of intracellular myelin.  The other part was incubated in 300µl 10% 
Sarkosyl for four hours at 4°C to separate Sarkosyl-insoluble fraction (SIF). After ultracentrifugation, 
the final pellet was used for Western blotting to detect modified aggregated MBP in sarkosyl-
insoluble fraction of cell lysates. We isolated purified myelin membrane from wild type mice, and 
extracted it with Sarkosyl to isolate Sarkosyl-insoluble pellet and use for western blotting.  
Figure 3.8 myelin fragments in the cells are associated with intracellular lipofuscin. A) co-labeling of 
myelin and lipofuscin using MBP antibody  (green) and seperated autofluorescent signal (Far red) in 
18 months old shows overlapping between internalized myelin fragment and intracellular lipofuscin. 
Scale bar: 2µm. B) 3D reconstruction of myelin fragments labeled with fluoromyelin and intracellular 
lipofuscin in 24 months old mouse confirms the association of myelin and lipofuscin. Scale bar: 2µm. 
C) Quantification of the number of microglia cells with internalized myelin included within lipofuscin 





An aggregation of a high-molecular weight (70kDa) fraction of MBP was found in cell lysate. After 
extraction in Sarkosyl the same fraction of MBP was recovered indicating that internalized MBP 
forms detergent-insoluble aggregates in microglia.  In sarkosyl-insolube fraction of pure myelin 










3.3.2 Age-related changes in microglia shape  
 
Iba1 antibody was used to visualize microglia cells in the mouse brain by immunohistochemistry in 
30µm thick sections.  To obtain the whole volume of an individual cell, 40 image stacks were 
acquired in z direction using confocal microscopy. Images were captured in different regions 
including corpus callosum, cortical white matter and gray matter. To assess the complexity and 
length of dendritic arbors of microglia the total area occupied by a single cell was measured by Imaris 
software as described before. The quantification was done in different region of brain for 40 cells per 
each mouse. The results showed that microglia in aged wild type mice (15 months old) have 
significantly smaller cell area than young mice (2 months old). Furthermore, all the cells with less 
branched processes contain large amount of lipofuscin (Fig 3.10). 
Figure3.9 Characterization of sarkosyl-insoluble fraction of isolated microglia. Left, Western blot 
analysis of purified microglia lysates from 12 months old mice shows MBP in the high-molecular weight 
region; MBP in myelin is shown as a reference in the right lane. Middle, high-molecular weight species 
of MBP existed in the Sarkosyl-insoluble (SIF) microglia membrane fraction (12 months old mice, 1 out 
of 5 representative experiments); MBP in myelin is shown as a reference in the right lane. Right, 
Sarkosyl extraction on purified myelin shows that myelin- associated MBP is Sarkosyl-soluble (Sarkosyl-
soluble membrane fraction, SF).   
 




3.3.3 Less motility of microglia processes in aging brain related to lipofuscin 
accumulation 
It has been shown that microglia processes are less motile in aged brain, (Damani, Zhao et al. 2011; 
Wong 2013) and this may be related to shorter and less branched processes of these cells. We tested 
whether there is a correlation between accumulation of lipofuscin within microglia and the motility 
of their branches. To examine this, live imaging of green fluorescent-labeled microglia in CX3CR1 GFP/+ 
young (3 months old) and aged (24 months old) mice was done to compare process motility of 
lipofuscin positive microglia versus cells with no lipofuscin in young mice. In two dimentinal 
maximum-intensity projections of time-lapse recordings for 15 minutes the area occupied by a 
process was measured every recording period of 32. Variance between the size of process area 
calculated every 32 seconds in 2 months old mice was 70028,72 while the variance for 24 months old 
mice was 26839,47. These numbers indicated that the branches of young microglia cells with almost 
no lipofuscin were more dynamic compared to microglia in old mice which accumulates lipofuscin 
(blue arrow (Fig 3.11). The calculation was done for 2 processes in 5 cells from each mouse. 
Figure 3.10 Aged microglia have less branched and shorter processes. A) The confocal images are 
showing a comparison between dendritic arborization of microglia in aged (24 months old) and young (2 
months old) wild type mice. Whereas cell processes are much more branched and longer in 2 months old 
mice, they are less complex and more retracted in aged microglia. Scale bar: 50µm. The images show that 
large lipofuscin granules are detected exclusively in the cells with less branched processes (a  and b). B) 
cell area quantification showed a decrease in the size of cell area of microglia in 15 months old compared 







3.3.4 Age-related changes in activation state of microglia 
The changes in the basal activation state of aged microglia is shown in previous studies (Rogers, 
Luber-Narod et al. 1988; Sheng, Mrak et al. 1998; Frank, Barrientos et al. 2006; Miller and Streit 
2007; Wong 2013).  Our histological studies showed MHCII positive cells were found in aged mice 
(18-24 month old) (Fig 3.12). In addition, we found an upregulation of Mac2 (Galectin 3) in aged 
mouse brain which was mainly restricted to the white matter. While there was no up-regulation of 
Mac3 during normal aging, the expression of Fcγ receptor II/III (CD16/CD32) and complement 
receptor 3 (Mac1) was detectable during normal aging, and there was no significant difference in the 
level of their expression among different age groups. Previous ex vivo and in vitro studies of aged 
microglia showed an increased expression of inflammatory cytokines including IL-1β, TNF-α, and IL-6 
(Ye and Johnson 1999; Sierra, Gottfried-Blackmore et al. 2007; Njie, Boelen et al. 2012).  However, by 
performing quantitative PCR for isolated microglia none of these cytokines was detected in aged 
mice. The reason for our negative finding could be that the expression of these cytokines in 
physiological condition is so low that cannot be detected in vivo. 
Figure 3.11 Dynamics of the motility of microglia processes in old and young mice regarding 
lipofuscin accumulation. Two dimensional maximum-intensity projections of time-lapse recordings 
from Green microglia in CX3CR1 GFP/+ mice for 15 minutes were achieved. 3D Reconstitution of a 
process of microglia cell showing the variation in area occupied by the process in 3 month and 24 
months old mice. The variation was considered every 128 seconds during recording period of 15 
minutes.  The process of microglia in young mouse shows a higher movement dynamics compared to 
that in old microglia containing a large amount of lipofuscin (blue arrow). Scale bar, 10µm (overview, 
3 months old) and 5µm (overview, 24 months old, and zoom in). 





3.3.5 Clearance function of microglia in aging 
We hypothesized that due to age-related accumulation of lipofuscin in aged microglia, clearance 
function of cells may decline. Therefore, we injected FITC-conjugated Dextran into the brain of wild 
type mice at the age of 2 and 10 months old. There was a 20% reduction in the number of cells with 
internalized dextran in middle aged (10 months old) compared to young (2 months old) mice. (Fig 
3.13). 
Figure 3.12 Analysis of the activation state of microglia in normal aging. DAB staining was done for 
brain sections of wild type mouse at the age of 2, 4, 7, 9, 18 and 24 months. Histological studies 
showed a small population of MHCII positive cells only in aged mouse brain (18-24 months old). The 
distribution of those cells is not restricted to a certain region of brain, they are found all over the 
brain. Scale bar: 50µm. CWM: Cortical White Matter, CC: Corpus Callosum, St: Striatum 
 
Figure 3.13 Clearance function of microglia in normal aging.  A) Quantification of Dextran positive 
(Dex+) cell number in 2 and 10 months old wild type mice. 1.5µg FITC-conjugated Dextran was 
injected in the cortex of brain (n=4) and 7 hours after injection, the mice were analyzed. Number of 
dextran positive cells in middle aged mice was 20% less than that in young animal. Mean value+SD 
was indicated. B) Confocal image of Dextran injection site in the cortex of brain in 10-month-old 
mouse showing that  Iba1 (red)/lipofuscin (gray) positive cells engulfed Dextran (green).  Scale bar: 





3.4 Enhanced myelin breakdown in demyelinating models and 
microglia behavior 
We speculated that increased myelin breakdown might induce aging-related changes in microglia. 
Therefore, we used three mouse models of demyelination, PLP overexpressing mice (a model for 
Pelizaeus-Merzbacher disease, (PMD mice), Cuprizone-induced demyelinating mice, and shiverer 
mice. In these mice, we analyzed three hallmarks of aging in microglia, lipofuscin formation, 
activation state, and uptake activity. 
 
3.4.1 Myelin in PMD mice and cuprizone model 
We analyzed PMD mice at the age of 2, 7, and 10 months old. These mice rarely survive beyond 10 
months of age. Figure 3.14 A shows the rate of demyelination during this time. At the age of 2 
months demyelination was not severe; compact myelin was detectable by MBP especially in corpus 
callosum. However, at later time points (7 and 10 months old) the level of demyelination increased 
showing myelin breakdown in the white matter. 
 In addition, we induced demyelination in wild type mice by Cuprizone treatment. In these mice 
demyelination was detectable mainly in corpus callosum 4 weeks after cuprizone treatment, and 
following 4 weeks of normal diet remyelination was induced. To distiguish between de and 
remyelination phase in cuprizone mice we used Fluoromyelin as shown in figure 3.14 B.   
  
Figure 3. 14 An overview of demyelination rate in PMD and cuprizone mice. A) Myelin was labeled 
with MBP. 2-month-old PMD mice showed normal myelination while in 7 and 10 months old animals, 
compact myelin could not be completely detectable. Scale bar: 30µm. B) de- and remyelination 
phases in cuprizone mouse. The compact myelin was labeled with Fluoromyelin. During 
demyelination the loss of myelin was detectable mainly in corpus callosum following 4 weeks of 
cuprizone diet. Completed remyelination was observed 4 weeks after feeding the mice with normal 
food. Scale bar: 300µm.     
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3.4.2 Microglia in PMD mice and cuprizone model  
 
3.4.2.1 Morphology and activation state  
 
PMD mice 
In PMD mice microglia accumulation was observed in corpus callosum and striatum where myelin 
breakdown was severe.  Myelin fragments were detected within microglia with very short and 
retracted processes (Fig 3.15 A). In addition, DAB staining showed that all the cells were totally 
activated with high expression of Mac2 and MHCII.  Compared to 2 month old mice, the population 
of activated cells in 7 and 10 months old was bigger (Fig 3.15 B). 
 
 
  Cuprizone-treated mice 
In cuprizone-treated mice the expression of Mac2 and MHCII in microglia was analyzed at different 
time points as shown in figure 3.16 A.  4 weeks after cuprizone treatment, when the demyelination 
was induced, a considerable number of MHCII positive cells were detected mainly in striatum and 
corpus callosum and a large population of Mac2 positive cells was found in the white matter as well. 
After 4 weeks of normal diet, when remyelination was ongoing, a considerable number of both Mac2 
Figure 3.15 Morphology and activation state of microglia in PMD mice. A) Confocal images of brain 
tissues of PMD mice at the age of 10 months old showing myelin phagocytosis by microglia (Iba1, 
red) with highly retracted branches in areas with myelin breakdown (striatum). Scale bar: 30µm 
(overview) and 5µm (zoom in). Quantification of the number of microglia engulfing myelin fragments  
in PMD mice. Student’ t-test, n.s: P=0.2865, One-way ANOVA, **p<0.01, mean values +SD was 
reported. B) At 2 months of age, Mac2 and MHCII positive cells are detected mainly in corpus 
callosum while these cells are highly populated all over the white matter such as corpus callosum and 






and MHCII positive cells were still detectable. Activation state of microglia cells was analyzed at later 
time points after completed remyelination (see the timeline diagram in figure 3.16. A, T: Time point). 
5 weeks after completed remyelination the expression of Mac2 and MHCII was mainly detectable in 
the corpus callosum. 11 and 19 weeks after completed remyelination, Mac2 was expressed by a 
small cell population in corpus callosum and striatum (Fig 3.16 B and D) whereas there was no MHCII 
positive cells detectable at these time points. (Fig 3.16 C and D) However, a significant number of 
MHCII reappeared 33 weeks (almost 8 months) after completed  remyelination in the comissura 
anterior (Fig 3.16 C, i)   Mac2 positive population was also found in the same region 33 weeks after 
complete remyelination (Fig 3.16 B, j).  
    
 
3.4.2.2 Lipofuscin accumulation in microglia in demyelinating models 
Next we tested whether the amount of lipofuscin was affected in demyelinating models. Therefore, 
as described before, lipofuscin was visualized and quantified at different time points in both PMD 
and cuprizone-treated mice.  Compared to age matched wild type mice, there was no significant 
Figure 3.16 Activation state of microglia in Cuprizone mice. A) Timeline diagram for cuprizone 
mice analysis (T: Time point). B, C) Quantification of the expression of MHCII and Mac2 in 
cuprizone mice after completed remyelination compared to untreated age-matched group. n=4, 
Mean value+SD was indicated, ***p<0.001. D) The expression of Mac2 (a-e) and MHCII (f-h) in 
cuprizone mice at different time points. 11 and 19 weeks after remyelination there was no MHCII 
positive cells detectable. (i and j) MHCII and Mac2 positive cells in anterior commissura 33 weeks 
after completed remyelination. CC: Corpus Callosum, St: Striatum. WPRe: Weeks Post 
Remyelinatio. Scale bar: 50µm.  
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change in  the amount of lipofuscin in PMD mice at 2 months of age while it increased drastically at 
later time points  (7 and 10 months old mice)  (Fig 3.17 A and B). In cuprizone-treated mice, 5, 11, 
and 33 weeks after completed remyelination, lipofuscin increased significantly in comparison to age 
matched untreated mice (Fig 3.17 C). 
Shiverer mice: In these mice, a population of unramified microglia with retracted unbranched 
processes was observed in the corpus callosum at 9 weeks of age. We detected lipofuscin inside 
those cells (Fig 3.17 E). In comparison with heterozygous shiverer mice, at 25 and 63 days of age 





Figure 3.17  Lipofuscin formation and quantification in demyelinating models.  A) Confocal images 
from PMD mice showing the development of intracellular lipofuscin (gray) in microglia (red), the size 
of lipofuscin increases with time. Scale bar: 20µm. Quantification of lipofuscin amount in PMD (B) 
cuprizone-treated (C) and shiverer (D) mice at different time points. n= 3-4 for each group of study.  
Mean +SD was indicated, *p <0.05, ***p<0.0001. E) Confocal images of microglia in corpus callosum 
in 9 weeks old shiverer mice. Microglia in this stage has retracted processes and intracellular 








3.4.2.3 Detection of myelin fragments within intracellular lipofuscin in cuprizone mice 
Previously we found that lipofuscin partially contains myelin fragments in physiological condition 
when the mice were more than 18 months old (See section 3.3.1.2). To confirm that, we analyzed 
cuprizone mice at the latest time point (33 weeks after completed remyelination), when microglia 
have a large amount of lipofuscin compared to untreated mice and were in contact with myelin 
debris dring de- and remyelination.  The mice were one year old at this time point. We labeled 
myelin with Fluoromyelin, microglia with Iba1, and visualized lipofuscin via autofluorescent signal. 
Using confocal images we could find co-localization of internalized myelin fragments with lipofuscin. 
In addition, the number of cells with Fluoromyelin-labeled myelin within lipofuscin was significantly 
higher in treated mice as compared to untreated mice (Fig 3.18 B) 
 
3.4.2.4 Clearance function of microglia in PMD mice 
We injected FITC-Dextran into the cortex of 7 months old PMD mice and quantified the number of 
microglia internalizing FITC-Dextran. Compared to age matched wild type mice, we found 50% 
reduction in clearance function of microglia in PMD mice (Fig 3.25) 
  
Figure 3.18 Myelin fragments are found within Lipofuscin in microglia in cuprizone mice 33 weeks 
after completed remyelination. A) Confocal image of lipofuscin (gray) within microglia (Iba1, red) 
containing myelin fragments (Fluoromyelin, green). Scale bars: 20µm (overview) and 2µm (zoom in). (a) 
3-D reconstruction of lipofuscin (gray) including myelin (green) within microglia (red). Scale bar: 1µm B) 
Quantification of the number of lipofuscin positive cells that contain myelin. 6 treated and untreated 
(age-matched) mice were analyzed.  Mean+SD was reported, **p<0.01, Student’s t-test. 







3.5 Genetically induced impairment of lysosomal degradation in 
microglia 
To analyze the effects of lysosomal storage on morphology and functionality of the cells we blocked 
the lysosomal degradation system specifically in microglia. This was achieved by crossing floxed Rab7 
mice to a Tamoxifen inducible CX3CR1 Cre mouse line.  Double transgenic mice (CX3CR1Cre+/-; 
Rab7flox/flox) were injected with Tamoxifen for 5 consecutive days to obtain conditional Rab7 knockout 
mice (Fig 3.20 A). We started to analyze the conditional knockout mice at different time points after 
Tamoxifen injection (Fig 3.20 B). 
 
3.5.1 Cre recombinase-mediated deletion of Rab7 gene in conditional Rab7 
knockout mice  
To evaluate deletion of Rab7 gene induced by Cre recombinase we performed two strategies as 
following. First, double transgenic mice were crossed to tdTomato reporter mice then CX3CR1+/CreERT2; 
Rab7flox/+; tdTomato+ mice were injected with Tamoxifen to induce Cre-mediated expression of 
tdTOmato in microglia. One week after Tamoxifen injection, histological studies showed that more 
than 95% of microglia in the brain were tdTomato positive, which indicated an efficient activity of cre 
recombinase in microglia (Fig 3.20 C). Second, one week after tamoxifen injection in CX3CR1Cre+/-; 
Rab7flox/flox mice, microglia cells were isolated to measure relative expression of Rab7 mRNA in the 
cells by quantitative real time PCR. The quantification showed a 98% reduction of Rab7 transcript (Fig 
3.20 D). 
Figure 3.19 Quantification of Dextran uptake by microglia in 7-month-old 
PMD mice. Dextran-FITC was injected in the cortex of 7 months old PMD and 
wild type mice, 7 hours after injection the mice were analyzed to measure 
the percentage of Iba1/Dex positive microglia in the injection site. The 
number of these cells is significantly lower in PMD mice compared to wild 








3.5.2 Phenotypic characterization of conditional Rab7 knockout mice 
3.5.2.1 Enlarged lysosomes in microglia 
Considering the role of Rab7 in maturation of lysosomes, we first investigated the lysosomal 
morphology of microglia in Rab7 knockout mice. Brain sections were co-labeled with Iba1 (against 
microglia) and LAMP1 (against lysosomes) using immunohistochemistry. Confocal images were 
captured to visualize lysosomes in microglia. We started our histological studies one week after Rab7 
deletion when we didn’t detect any changes in lysososmes within microglia. However, enlarged 
Figure 3.20 Evaluation of Rab7 gene deletion in conditional Rab7 knockout mice. A) Strategy for 
conditional targeting of Rab7 in mice. B) Timeline diagram for histoglogical analysis of conditional 
Rab7 knockout mice. C) Confocal image from cortex in CX3CR1+/CreERT2; Rab7flox/+; tdTomato+ mice. 
One week after Tamoxifen injection, microglia were visualized with Iba1 in green and the number of 
Iba1+/tdTomato+ (red) cells were counted. The quantification showed that tdTomato was expressed 
in 95% of microglia, Scale bar: 300µm. D) Relative expression of Rab7 mRNA in microglia one week 
after Tamoxifen injection in double transgenic mice (CX3CR1Cre+/-; Rab7flox/flox). 98% of Rab7 transcript 
was reduced.  
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lysosomes appeared only 6 weeks after Rab7 deletion when the mice were 10 weeks old (Fig 3.21 A). 
At this time point there was no detectable lysosomes in microglia of control group. Enlarged 
lysosomes were detectable in microglia of Rab7 knockout mice at later time points (10, 18, and 26 
weeks after Tamoxifen injection) as well.  Quantification of the number of LAMP1 positive showed 
that almost 50% of microglia cells have enlarged lysosomes in conditional Rab7 knockout mice (Fig 
3.21 B).  
 
3.5.2.2 Myelin fragments inside microglia  
To study the interaction between microglia and myelin in conditional Rab7 KO mice, myelin and 
microglia were labeled with MBP and Iba1, respectively by immunohistochemistry. The labeled brain 
tissues of KO and control groups were analyzed 6, 10, 18, 26, 34, and 48 weeks after tamoxifen 
injection to detect myelin phagocytosis by microglia. Myelin fragments were detected inside 
microglia in KO mice 34weeks after Tamoxifen injection, when the mice were 9 months old (Fig 3.22 
A). In wild type mice internalized myelin was detected only at 18 months of age (Section 3.2.2). The 
number of cells with internalized myelin components was quantified in 1mm2 of white matter 










Figure 3.21 Visualization and quantification of LAMP1-positive microglia in conditional Rab7 
knockout mice. A) Enlarged lysosomes (labeled with LAMP1 in red) are detectable within microglia 
(labeled with Iba1 in green) 6 weeks after Tamoxifen injection. Scale bar: 20µm. B) The percentage of 
LAMP1-positive microglia cells in the cortical white matter in Rab7 knockout mice 6, 10, 18, and 26 









3.5.2.3 Early accumulation of lipofuscin in microglia  
Immunohistological studies showed that a considerable amount of lipofuscin accumulated inside 
microglia in KO mice at very early time point (6 weeks after Tamoxifen injection) when the mice were 
only 10 weeks old. Quantification of the volume of lipofuscin 6, 18, 34, and 48 weeks after tamoxifen 
injection showed a significant increase in the amount of lipofuscin in KO mice in comparison with 




3.5.2.4 Myelin fragments are associated with lipofuscin within microglia 
To search for myelin remnants within lipofuscin, myelin was labeled with MBP and Fluoromyelin. 
Myelin and lipofuscin were visualized simultaneously using dye separation method with confocal 
Figure 3.22 myelin phagocytosis by microglia in conditional Rab7 KO mice. A) Confocal image 
representing myelin components (MBP, green) within microglia (Iba1, red) in striatum of a 9-
month-old KO mouse (34 weeks after Tamoxifen injection). B) Quantification of the percentage of 
cells engulfing myelin fragments at the same time point. Each group: n=3, Mean+SD was indicated, 
*p<0.05, Student’s t-test. 
 
Figure 3.23 Lipofuscin in conditional Rab7 KO mice. The 
volume of lipofuscin in the cells was measured in the 
callosum and cortical white matter using Imaris software. 
The amount of lipofuscin in microglia in KO mice is 
significantly higher than that in control mice at all the time 
points. Three mice per group were analyzed and mean 
value plus SD is indicated.  ***p<0.0001, Student’ t-test. 
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microscopy as explained before. We found MBP or Fluoromyelin positive lipofuscin granules 34 and 




3.5.2.5 Clearance function of microglia in conditional Rab7 KO mice 
Due to early accumulation of lipofuscin as well as lysosomal dysfunction in microglia in Rab7 KO mice 
we assumed that the clearance function of the cells might be impaired. FITC-Dextran was injected 
into the cortex of KO and control mice 6 and 18 weeks after Tamoxifen injection. Clearance function 
of microglia in KO mice was significantly reduced only at the later time point (18 weeks after 
Tamoxifen injection) while there was no significant difference between control and KO mice at 
earlier time point, 6 weeks after Tamoxifen injection (Fig 3.25) 
Figure 3.24 Lipofuscin contains 
internalized myelin fragments in 
microglia in Rab7 KO mice. A) 48 weeks 
after Tamoxifen injection when the mice 
were 12 months old, myelin fragments 
(MBP, green) were detected inside 
microglia (Iba1, red) while they were 
associated with intracellular lipofuscin 
(LF, gray). Scale bar: 20µm (overview) 
and 2µm (zoom in). B) 3-dimensional 
reconstruction showing Fluoromyelin-
labeled myelin fragment (green) within 
lipofuscin (gray) inside a single microglia 
cell Scale bar: 2µm C) Quantification of 
the number of cells with internalized 







3.5.2.6 Myelin fragments in conditional Rab7 KO mice 
We quantified the number of myelin fragments in electron microscopic images from white matter, 
mainly corpus callosum, in KO and control mice 48 and 77 weeks after Tamoxifen injection. At both 





3.5.2.7 Microglia morphology in conditional Rab7 KO mice 
Microglia were analyzed in Rab7 KO mice morphologically using immunohistochemistry. Compared 
to control group, microglia in KO mice showed smaller and less complex processes 6 weeks after 
tamoxifen injection (Fig 3.27 A). In addition, the surface area occupied by microglia processes in KO 
mice was reduced compared to control mice (Fig 3.27 B). Although the KO mice at this time point 
were only 10 weeks old, the morphology of microglia was comparable to those of aged microglia.  
Figure 3.25 Clearance function of microglia in conditional 
Rab7 KO mice. Dextran was injected into the cortex 6 and 
18 weeks after Tamoxifen injection; 7 hours after injection, 
the number of Iba1/Dex+ cells was counted. There was no 
difference in clearance function of cells between KO and 
control mice 6 weeks after Tamoxifen injection. There was a 
50% reduction in the number of Dextran positive microglia 
in KO mice in comparison to control group at later time 
point (18 weeks after Tamoxifen injection). n=4, mean+SD,  
**p value<0.01, n.s: p= 0.3206,  Student’s t-test. 
Figure 3.26 Number of myelin fragments increases in 
conditional Rab7 KO mice. Brain tissues from control and KO 
mice 48 and 77 weeks after Tamoxifen injection were 
prepared for conventional electron microscopy. The number of 
myelin fragments was counted per 1000 axons. The 
quantification shows that myelin fragments in KO mice are 
significantly more than control groups at both time points.  
 
 




3.5.2.8 MHCII expression in microglia in conditional Rab7 KO mice 
To assess the activation state of microglia in KO mice, using DAB histostaining, we evaluated 
expression of Mac2, Mac3, MHCII, CR3(CD11b/ Mac1), Fcγ RII/III, at different time points (18, 26, 34, 
48 and 77 weeks after Tamoxifen injection). The results showed that there were no Mac3 positive 
cells in any of the mice, and there was no significant difference in number of CR3 and Fcγ RII/III 
positive cells between KO and control mice 26, 34, 48, and 77 weeks after Tamoxifen injection. In 
addition, Mac2 and MHCII were not expressed in both KO and control mice 18, 26, and 34 weeks 
after Tamoxifen injection. The number of MHCII positive cells in KO mice 48 and 77 weeks after 
Tamoxifen injection was significantly higher compared to control group.  
Figure 3.27 morphological analysis of microglia in Rab7 KO mice. A) Confocal image of microglia 
population in cortical white matter 6 weeks after Tamoxifen injection showing shorter and less 
branched processes in KO compared to control mice.  Scale bar: 30µm. B) Quantification shows that 
cell area of microglia in KO mice is significantly less than cell area in control group. ***p < 0.0001, 
Mean value+SD.   
 
Figure 3.28 MHCII expression in microglia of Rab7 KO mice. A) A 
few MHCII positive cells were detected in Rab7 KO mice 48 weeks 
after Tamoxifen injection in cortical gray matter (a), cortical white 
matter (b), striatum (c), hippocampus (d) and corpus callosum (e). 
Scale bar: 50µm. B) Quantification of MHCII positive cell in Rab7 KO 
and control mice 26, 48, and 77 weeks after Tamoxifen injection 
showing a significant increase in KO mice at later time points 
compared to their control group. n=3, Mean plus SD was 





4.1 Myelin turnover by shedding of myelin fragments into the 
extracellular space  
Myelin is a tightly packed membrane in which the protein and lipid molecules are sandwiched 
between compacted layers. This special membrane has been considered as one of the most stable 
membranes. Myelin molecules have little contact with the metabolic pool in the cytoplasm so that 
they exhibit a low rate of metabolic turnover (O'Brien 1965). Previously, the turnover rate of some 
myelin lipids and proteins were determined using isotope-labeling and mass spectrometry (MS). 
Sphingomyelin, gangeliosides, cerebroside, and cholesterol were found to have low rate of 
metabolism. Proteolipid protein (PLP) with the half-life of 20-35 days was reported as metabolically 
active myelin component (Smith 1968; Fischer and Morell 1974; Ando, Tanaka et al. 2003). The 
incorporation of tyrosine into the myelin proteins using [14C] tyrosine showed that only 20 % of 
myelin proteins were replaced within 10 days (Lajtha, Toth et al. 1977)  
Due to the heterogeneity of myelin structure, the turnover rates of myelin lipids and proteins are 
heterogeneous. (Smith 1968; D'Monte, Mela et al. 1971; Sabri, Bone et al. 1974; Poduslo and Braun 
1975; Figlewicz and Druce 1976; Lajtha, Toth et al. 1977; Singh and Jungalwala 1979). Myelin proteins 
that have access to the metabolic machinery might have higher turnover rate (Lajtha, Toth et al. 
1977). Iodination studies showed that MBP is less exposed to the outer surface compared to PLP 
(Poduslo and Braun 1975). Recently, using pulse-chase labeling and mass spectrometry, myelin 
proteins such as MBP, PLP, and MOG were reported as long-lived myelin proteins (Toyama, Savas et 
al. 2013).  
Long-lived proteins are at increased risk for accumulation within the cells which can be linked to the 
cellular aging process (Toyama, Savas et al. 2013). Therefore, structures like myelin membrane 
exhibiting long-term protein persistence need to be maintained or remodeled. Studies in human and 
rodents claimed that myelin is continuously exchanged (Lasiene, Matsui et al. 2009; Young, 
Psachoulia et al. 2013; Yeung, Zdunek et al. 2014). Studies in human brain suggested that preexisting 
mature oligodendrocytes are responsible for myelin modulation.  Oligodendrocytes in human show a 
very low rate of turnover. After 9 years of age the number of oligodendrocytes remains stable 




turnover and myelin remodeling that occurs at a high rate in human. However, several observations 
in the rodents indicate that oligodendrocyte turnover contributes to myelin remodeling (Dimou, 
Simon et al. 2008; Emery 2010; Young, Psachoulia et al. 2013). 30% of all oligodendrocytes in the 
corpus callosum in adult mice are newly differentiated (Rivers, Young et al. 2008; Zhu, Whittemore et 
al. 2011). Adult oligodendrocytes are thought to be required for the maintenance of myelin by the 
replacement or remodeling of preexisting myelin sheaths (Young, Psachoulia et al. 2013). For the 
remodeling of myelin, new myelin segment appears to displace old myelin segments  (Wang and 
Young 2014). Internode retraction and expansion of the node of Ranvier due to disruption of key 
proteins lead to a transient hypofusion. This mechanism is suggested to play a role in myelin 
remodeling (Reimer, McQueen et al. 2011).   
It still remains to be understood how the old segments of myelin sheath are removed from axons. 
How the molecules that are trapped within closely compacted membranes get access to the 
degradation system for myelin turnover during long period of time. Using electron microscopy, we 
detected multilamellar myelin fragments in the intracellular and extracellular space in adult and aged 
mice. We noticed that a large part of myelin sheath tears away from the axon (Fig 4.1 A).  In addition, 
light microscopic histology in the striatum, interestingly, showed that a part of myelin is pulled by 
microglia in aged mice (Fig 4.1 B). We propose that myelin fragments can be formed by shedding of 
myelin sheaths into the extracellular space.  
4.2 Myelin uptake by microglia  
The processes of microglia in their ‘’resting’’ state in vivo are highly motile to survey the 
microenvironment in the CNS and also to interact with synapses (Nimmerjahn, Kirchhoff et al. 2005; 
Wake, Moorhouse et al. 2009). We speculated that resting microglia have also potential functions in 
myelin turnover in the CNS. Our work showed that microglia processes are in contact with myelin in 
Figure 4. 1 Myelin fragments are formed by shedding of myelin sheaths into the extracellular space 
A) Elecron microscopic image in the corpus callosum showing myelin tearing away from the axon. B) 
Confocal image in striatum of 18 months old mouse showing a microglia (Iba1, red) pulling a part of 
myelin (MBP, green) into the extracellular space. The middle image shows the same phenomenon in 
a rotated position.  Scale bar, 5µm (left); 4µm (middle and right).   




physiological condition. The frequency of these contacts and also the surface area in contact with 
myelin increase with age, starting at least at 9 months of age.  In addition, myelin fragments were 
detected inside microglia cells in striatum as well as cortical white matter at 18 months of age and 
later. Consistent with previous observations, we found an age-dependent increase in the number of 
microglia cells in the white matter (Sandell and Peters 2002). Moreover, compared to gray matter, a 
considerable number of cells expressing Mac2/Galectine 3 were observed in the white matter. 
Interestingly, this population was detectable only in aged mice. Mac2/Galectine 3 is a galactose-
binding lectin which appears to be active in demyelination of peripheral nerves (Saada, Reichert et al. 
1996). Mac2/Galectine 3 is also known to be upregulated in demyelination areas in EAE, and is 
expressed by microglia, macrophages that phagocytose myelin (Reichert and Rotshenker 1999; Smith 
2001; Rotshenker, Reichert et al. 2008; Rotshenker 2009). Additionally, while lysosomes were rarely 
detectable in young microglia, they appear from 7 months of age on. Also, in both middle aged and 
aged mice, lysosomes are strikingly larger in the white matter than in gray matter. This finding 
suggests that the lysosomal system of microglia cells is actively engaged in degradation of myelin. 
Previous studies have shown an increase in the number of CD68 positive microglia cells which are 
involved in the engulfment of synaptic elements in the postnatal retinogeniculate system. CD68 is a 
marker for lysosomes (Schafer, Lehrman et al. 2012). Moreover, our results are consistent with 
previous work that has shown an increase in the number of ED1, a lysosomal marker, positive 
microglia in corpus callosum with age (Hua, Schindler et al. 2012)  Altogether, our results indicate 
that microglia cells are actively involved in the removal of myelin in normal aging.   
 
4.3 Age-related increase in microglia-myelin contact is correlated 
with higher rate of myelin turnover in aging  
Electron microscopic studies have revealed that during aging myelin sheaths undergo some 
structural alterations that make the membrane unstable and prone to degeneration (Peters 2002). In 
this context, it has been shown that in aged mice the replacement of some molecules such as 
cerebroside and GM1 is relatively accelerated and metabolic turnover of myelin is slightly higher 
(Ando, Tanaka et al. 2003). Previous studies on oligodendrocytes in aged brain of monkeys have 
detected dense inclusions which aggregate in the cell body or develop swellings at the end of 
processes (Peters 2002). These inclusions are suggested to originate from degenerating myelin 
membranes and turnover of material in the sheaths. In some oligodendrocytes, the swelling was 




To maintain the integrity of myelin, unstable molecules must be removed either from axons or from 
oligodendrocytes. Accordingly, our studies show that microglia can be responsible for clearing 
degenerated myelin in aged brain of mice. Our results specifically shows that myelin molecules such 
as MBP which are trapped within layers of tightly compacted membrane are transferred to microglia 
by fragmentation of myelin in the extracellular space. The other possibility is that myelin components 
are outsourced by oligodendrocytes into the extracellular space.  
In adulthood, myelin is remodeled or replaced by new myelin sheaths that are produced by adult-
born oligodendrocytes (Wang and Young 2014). These cells, intrinsically, generate shorter myelin 
segments not only in adulthood but also in aging to actively myelinate the axons which have not 
been myelinated in development (Lasiene, Matsui et al. 2009; Young, Psachoulia et al. 2013). These 
studies suggest that myelination continues from development to adulthood as well as aging. 
Therefore, the old segments from pre-existing myelin sheaths during remodeling of myelin 
membrane as well as myelin disposal generated due to de novo myelination must be removed 
efficiently for the maintenance of myelinated fibers.  
 
4.4 Internalized myelin contribute to the formation of lysosomal 
inclusions  
The normal functionality of microglia cells is essential for the integrity of the CNS in healthy as well as 
pathological conditions. During the life span of an animal, microglia cells are targeted with the aging 
that cause changes in their morphology and functions (Ajami, Bennett et al. 2007; Streit and Xue 
2010). Therefore, it is important to define the factors which induce age-related alterations in these 
cells. 
Consistent with other studies we could also detect an aging phenotype in microglia in wild type mice. 
One of the most specific hallmarks of aging in microglia is lipofuscin accumulation, defined as 
lysosomal inclusions (Sierra, Gottfried-Blackmore et al. 2007; Tremblay, Zettel et al. 2012). There was 
an age-related increase in the number and amount of intracellular lipofuscin. It is notable that 
lipofuscin was not totally absent from cells in young (2 months old) mouse brain, but was detectable 
only in very small amount.  Formation of lipofuscin even in the early time of life is thought to be due 
to oxidative reactions which are important for the survival of the cell during the lifetime (Terman and 
Brunk 1998). In middle aged and aged mice, lipofuscin positive microglia cells were found all over the 
brain. However, interestingly, microglia in the white matter have larger amount of lipofuscin 
compared to gray matter. In addition, we found that internalized myelin fragments are frequently 




associated with lipofuscin. The main reason for lipofuscin formation is thought to be age-related and 
(reactive oxygen species) ROS-mediated oxidative stress. Endogenous ROS which is mainly derived 
from mitochondria cause oxidative damage to the internalized material in lysosomes so that they 
become undegradable and form lipofuscin (Terman and Brunk 1998; Terman, Kurz et al. 2010). 
Therefore, lipofuscin is considered as a mixture of oxidized proteins and lipids (Gray and Woulfe 
2005). Myelin proteins and lipids are known to be susceptible to ROS-induced oxidation (Bongarzone, 
Pasquini et al. 1995; Luoma, Kuo et al. 2015). This type of oxidation is mainly mediated by iron which 
increases with age and accumulates within lipofuscin (Brunk 1989; Gray and Woulfe 2005; Wong 
2013). Myelin membrane exposure to iron-catalyzed free radical generation system induces protein 
aggregation and lipoperoxidation (Konat, Gantt et al. 1986; Domanska-Janik and Bourre 1990). 
Altogether, we suggest that myelin components which are engulfed by microglia with time undergo 
oxidative damage so that accumulate within the cell as a part of lipofuscin. 
 
4.5 Microglial phenotype changes with age 
 We observed that lipofuscin positive cells have shorter and retracted branches, and are less motile. 
Other studies have also shown that aged microglia cells in the brain as well as retina have less 
branched processes, reduced arborization and motility (Sierra, Gottfried-Blackmore et al. 2007; 
Damani, Zhao et al. 2011). We found a correlation between the presence of intracellular lipofuscin 
and ramification as well as motility of their processes. The latter characteristics of microglia are 
required for the surveillance function. Because of less dynamic and ramified processes of aged 
microglia, the cellular migration of cells toward a local lesion is not as efficient as in young cells. 
Consequently, their immune responses may become slower. Moreover, following injury, aged cells 
represent a delayed dynamics of deactivation; they are not dispersed from the lesion site after a long 
time (Damani, Zhao et al. 2011).  Sustained accumulation of activated aged cells avoids the 
maintenance of tissue homeostasis and may induce chronic neuroinflammation involved in the 
pathogenesis of age-related neurodegenerative diseases (Medzhitov 2008; Damani, Zhao et al. 
2011). Furthermore, it is known that the aggregation of undigested materials within the cells leads to 
deficient clearance function. For example, oxidized lipoprotein-loaded macrophages, known as 
foamy cells in atherosclerosis, are inefficient in clearance of apoptotic bodies (Schrijvers, De Meyer et 
al. 2007; Ley, Miller et al. 2011). We expected that aged microglia with accumulation of lipofuscin, a 
mixture of oxidized proteins and lipids, also show an impaired clearance function. Following injection 
of Dextran-FITC in the cortex of young (2-month-old) and middle aged (10-month-old) mice, we could 




Barrientos et al. 2006). Overall, we suggest that lipofuscin can be considered as a biomarker of 
senescent and dysfunctional microglia.  
 
4.6 Myelin breakdown leads to lipofuscin formation   
In summary, our results show that in aging brain, myelin is fragmented and taken up by microglia 
where it is partially included within lipofuscin, and that lipofuscin positive cells represent a 
senescence-type of phenotype. We asked whether there is a casual correlation between myelin 
uptake by microglia and their aging phenotype. We assumed that overloading the lysosomal system 
with myelin may induce microglia senescence. Therefore, we analyzed microglia in demyelinating 
mouse models in which the cells are exposed to large amount of myelin fragments due to enhanced 
myelin breakdown. Immunohistochemical analysis of dysmyelinating mouse model for Pelizaeus-
Merzbacher disease, which overexpress plp 1 gene (PMD mice), at different age, (2, 7, and 10 months 
old) showed that the stability of myelin is reduced with time and consequently, myelin sheaths were 
broken-down. Loss of myelin was accompanied with accumulation of microglia expressing MHCII and 
Mac2 in the white matter. These observations are in consistent with the studies that characterized 
these mice previously (Karim, Barrie et al. 2007; Edgar, McCulloch et al. 2010; Tatar, Appikatla et al. 
2010). We frequently found myelin fragments within these cells at later time when demyelination 
was peaking (10 months of age). In addition, by comparing transgenic mice at different age we 
detected a significant increase in the amount of intracellular lipofuscin with time. There was no 
difference between PMD and wild type mice at 2 months of age when the myelin was still stable. 
Compared to age-matched wild type mice there was a striking increase in the quantity of lipofuscin in 
7 as well as 10 months old PMD mice in which the stability of myelin sheaths was compromised. The 
difference between 10 months old PMD mice and wild type was bigger than difference between 7 
months old PMD mice and wild type. Altogether, these data showed that the accumulation of 
lipofuscin overlaps with the level of myelin breakdown in these mice.  
Next, we observed that microglia in 7 months old PMD mice have a reduced capacity to clear away 
dextran particles from the extracellular space. Therefore, considering the high level of myelin 
fragmentation in these mice we suggest that overwhelming the cells with myelin fragments and 
consequently, lipofuscin affects their clearance function.  
Next to demyelination, PMD mice develop axonal degeneration due to inflammation and 
oligodendrocyte dysfunction (Anderson, Schneider et al. 1998; Edgar, McCulloch et al. 2010). Thus, in 
these mice the formation of inclusions in microglia may results from engulfment of not only myelin 




but also axonal elements. Therefore, to avoid the contribution of other factors besides myelin, we 
used shiverer mice in which there is no sign of axonal change or loss and the pathology is restricted 
to myelin (Griffiths, Klugmann et al. 1998). In these mice, myelin breakdown occurs due to lack of 
MBP already in development (Roach, Takahashi et al. 1985). Previous studies have reported that 
there is no macrophage infiltration in shiverer mice (Bird, Farrell et al. 1978). However, we could 
detect a massive accumulation of microglia in the corpus callosum in these mice at P25 as well as 
P63. These cells have a significant amount of lipofuscin indicating that myelin degeneration 
contributes to its accumulation. 
In these models, demyelination or dysmyelination are continuous processes. We asked whether a 
short-term exposure of myelin to the cells would be also sufficient to enhance aging at a later time.  
To test this, we induce a singular event of demyelination for 4 weeks by cuprizone treatment of wild 
type mice, and then induce remyelination by changing cuprizone to the normal diet. According to 
previous studies (Matsushima and Morell 2001; McMahon, Suzuki et al. 2002), microglia remain in 
their activation state 4-6 weeks after removing cuprizone from the diet. Thus, we started our 
histological studies 4 weeks after diet change, when remylination was completed, to differentiate 
phenotypic changes that might occur as a result of activation from those produced as a consequence 
of aging. As the main hallmark of aging we quantified the volume of lipofuscin in microglia cells at 
later time points after completed remyelination. In comparison with the control mice, the amount of 
lipofuscin increased significantly in cuprizone-treated mice already 5 weeks after completed 
remyelination and continued to increase 11 and 33 weeks after completed remyelination. In 
addition, interestingly we could find myelin fragments associated with lipofuscin even 33 weeks after 
complete remyelination, confirming our previous data that showed the association of internalized 
myelin with lipofuscin in wild type conditions.  
Further investigation of cuprizone mice showed that MHCII and Mac2 were up-regulated in corpus 
callosum 5 weeks after completed remyelination. These up-regulations were expected as an 
indication of microglia activation in this time point. Interestingly, while Mac2 positive cells were still 
detectable 11, 19, and 33 weeks after complete remyelination, MHCII expression went back to the 
basal level and reappeared only at week 33 after complete remyelination. These data indicate that 
low grade inflammation which is normally characteristic of microglia senescence occurs earlier when 
the brain has undergone a single event of widespread demyelination. Moreover, expression of Mac2 
at all the time points can be explained regarding its role in myelin phagocytosis during demyelination 
(Smith 1999; Smith 2001). Notably, at the latest time point in cuprizone mice Mac2 expressing cells 
were found mainly in anterior commissure, and previously in aged wild type mice we also detected 




normal aging the contact of microglia with myelin fragments, produced due to myelin sheaths 
breakdown, keeps the cells in a mild activation state that mainly appears as Mac2 expression. Studies 
on demyelinating models, including PMD, shiverers, and cuprizone mice, suggest that myelin 
breakdown can accelerate age-related phenotype in microglia cells.   
 
Myelin consists of long-lived proteins (Lajtha, Toth et al. 1977; Ando, Tanaka et al. 2003; Toyama, 
Savas et al. 2013). Long-lived proteins are thought to have implications for age-dependent deficiency 
in the cells and tissues. These components are possibly at the risk of damage during a long period of 
time (Toyama, Savas et al. 2013). For example, it was shown that accumulation of damaged 
crystalline with time cause vision deficiency (Bloemendal, de Jong et al. 2004; Wilmarth, Tanner et al. 
2006). Long-lived scaffold nucleoporins undergo oxidative damage during aging that is associated 
with defects in nuclear trafficking and the breakdown of the nuclear permeability barrier (D'Angelo, 
Raices et al. 2009). Due to the nature of myelin components, they are thought to be vulnerable to 
the iron-catalyzed proxidation occurring normally in lysosome for degradation (Bongarzone, Pasquini 
et al. 1995; Luoma, Kuo et al. 2015). Therefore, these components become indigestible with time. 
The constant contact of non-dividing cells such as microglia with myelin cause lysosomal storage 
which can be linked to deficient clearance function (Schrijvers, De Meyer et al. 2007) and possibly 
age-related features.   
 
4.7 Lysosomal storage induces cellular senescence 
We asked how microglia senescence is induced. We could show that when the cells are exposed to 
myelin fragments or overloaded with them, the amount of intracellular lipofuscin increases and pre-
mature aging phenotype is induced. Therefore, we suggested that overloading the lysosomal system 
with time may influence the functionality of microglia and induce cellular senescence. To test this, 
we generated conditional Rab7 Knockout mice in which the cargo transport from endosomes to 
lysosomes is blocked so that a pile of material in degradative compartments accumulates within 
microglia. In these mice, enlarged lysosomes, as an indication of lysosomal dysfunction, were 
detectable in the cells only 6 weeks after Tamoxifen injection and not earlier than that although just 
one week after Tamoxifen injection more than 98% of Rab7 transcript was already deleted. We 
assumed that at the earlier time point, residual pool of Rab7 protein in the cytosol still can 
compensate the functionality of lysosomes in the cells. It is notable that the enlarged lysosomes 
were detectable for 48 weeks after Tamoxifen injection which shows stability of microglia in the CNS 
(Lawson, Perry et al. 1992) 
 




Interestingly, the hallmarks of senescence, including lipofuscin accumulation and shorter and less 
branched cell processes, were detected in microglia in Rab7 KO mice already when the mice were 10 
weeks old. Moreover, regardless the normal aging effect, at later time points, the amount of 
lipofuscin significantly increased in Rab7 KO mice in comparison with control mice. The clearance 
function of cells decreased significantly with time. Possibly, due to higher amount of indigestible 
materials, lysosomes are more exhausted at later time so that the cells are not efficient enough for 
clearance. These data are comparable with our previous results that showed less clearance activity in 
aged cells with high amount of lipofuscin, and also with other studies shown that lysosomal storage 
in phagocytic cells cause a defect in clearance of apoptotic bodies (Schrijvers, De Meyer et al. 2007). 
Due to deficient clearance function of microglia cells in Rab7 KO mice a higher number of 
extracellular myelin fragments in the white matter was found confirming that microglia cells are 
responsible for myelin fragments removal in aging.  
At the age of one year a few cells expressing MHCII were detected while there was no positive cell in 
control mice. Altogether, the results show that impairment of lysosomal degradation system induces 
a pre-mature aging phenotype in microglia. We propose that there is a reciprocal correlation 
between aging and lyososomal function. While aging factors, mainly oxidative stress, affects the 
functionality of the lysosomes (Kurz, Terman et al. 2008), dysfunctional lysosomes may induce 
cellular aging. 
We found that Rab7 KO mice develop intracellular MBP positive myelin fragments more frequently 
compared to control group. Furthermore, myelin uptake by microglia in Rab7 KO mice was detected 
9 months earlier than in wild type. The internalized myelin fragments were found in association with 
lipofuscin more abundant in KO mice. Overall, using this mouse model we could confirm our previous 
results showing that in normal aging myelin fragments are constantly taken up by microglia and 
partially get trapped within intracellular lipofuscin. 
 
4.8 conclusion 
In summary, we suggest that myelin breakdown plays a role in inducing microglia dysfunctionality 
that occurs in the aging brain. Increasing rate of myelin turnover in demyelinating models as well as 
in normal aging cause cells to become overloaded with myelin fragments with time, and develop 
lysosomal storage pathology, which consequently induce aging.  
Our results may have important implication for neurodegenerative disease. If constant transfer of 
myelin fragments may block the lysosomal system and consequently impairs the function of 




For example, in Alzheimer’s disease, it is known that the capacity of microglia to remove β-Amyloid 
goes down with time.  
Our findings may explain why prior traumatic brain injury (TBI) associated with tissue breakdown acts 
as a risk factor for chronic neurodegenerative diseases. We propose that a long term exposure to 
myelin debris or neuronal elements cause microglia cells to be overloaded so that they become 
exhausted and may lose their function to clean brain from more debris.  
Furthermore, our results may also be important for the pathophysiology of CNS autoimmune 
diseases such as multiple sclerosis. In this disease, myelin is known to be the most common target of 
autoimmune responses (Steinman and Zamvil 2003; Fletcher, Lalor et al. 2010). However, according 
to immunopathology of MS, it is not well understood how myelin antigens reach antigen presenting 
cells in the CNS to reactivate auto-reactive T cells in the parenchyma (Goverman 2009; Hart, Hintzen 
et al. 2009). We suggest that the permanent circulation of myelin-derived components in the brain 
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